carbapenems has been researched along with cephalosporin c in 558 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (cephalosporin c) | Trials (cephalosporin c) | Recent Studies (post-2010) (cephalosporin c) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 20,476 | 2,093 | 4,152 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (1.08) | 18.7374 |
| 1990's | 61 (10.93) | 18.2507 |
| 2000's | 111 (19.89) | 29.6817 |
| 2010's | 233 (41.76) | 24.3611 |
| 2020's | 147 (26.34) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, S; Kanemitsu, K; Nakashio, S; Shimada, J; Shoji, Y; Yanagawa, A | 1 |
| Liu, C | 1 |
| Tabuki, K | 1 |
| Hopkins, JA; Lami, JL; Wilson, SE | 1 |
| Reed, RL | 1 |
| Aldridge, KE; Karam, GH; Sanders, CV | 1 |
| Neu, HC | 1 |
| Bergogne-Berezin, E | 2 |
| Butler, K; Gress, J; Lecciones, J; Lee, J; Marshall, D; Pizzo, PA; Roilides, E; Rubin, M; Walsh, T; Weinberger, M | 1 |
| Mitsuhashi, S; Yoshida, M | 1 |
| Giroir, AM; Grosset, J; Jarlier, V; Nicolas, MH; Philippon, A | 1 |
| Castellani, P; Della Bruna, C; Rossi, R; Younes, G | 1 |
| Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E | 1 |
| Chanal, C; Labia, R; Morand, A; Sirot, D; Tiwari, K | 1 |
| Chin, NX; Labthavikul, P; Neu, HC | 1 |
| Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T | 1 |
| Chen, HY; Livermore, DM; Yuan, M | 1 |
| Cormican, MG; Jones, RN | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Niemeyer, DM | 1 |
| Galanakis, N; Giamarellou, H; Voutsinas, D | 1 |
| Hamilton-Miller, JM | 1 |
| Byrne, S; Connor, P; David, TJ; Dodd, M; Doughty, I; Jenney, M; Maddison, J; Webb, AK | 1 |
| Edwards, JR; Nairn, K; Shepherd, GL | 1 |
| Schuler, D | 1 |
| Fukuhara, J; Kouda, M; Matsuzaki, H; Tamura, K; Udagawa, I | 1 |
| Egleton, JH; Mortensen, JE | 1 |
| Devalckenaere, A; Husson, MO; Izard, D; Vachée, A | 1 |
| Livermore, DM; Yuan, M | 1 |
| Jiang, GZ; Kato, Y; Kido, N; Koide, N; Kusumi, A; Narita, K; Sugiyama, T; Takahashi, K; Yokochi, T | 1 |
| Suppola, JP; Vaara, M; Valtonen, VV; Volin, L | 1 |
| Abe, S; Bando, T; Hiraga, Y; Hirano, H; Inoue, H; Ito, T; Kawakami, Y; Kikuchi, K; Koba, H; Kobayashi, H; Matsumoto, H; Mouri, T; Nakashima, M; Ohmichi, M; Ohsaki, Y; Saito, A; Sakamoto, M; Shirato, K; Takahashi, M; Takeuchi, K; Tanifuji, Y; Tanno, Y; Yamaguchi, E; Yoshida, M | 1 |
| Blumer, JL; Bonafede, ME | 1 |
| Matsumura, N; Minami, S; Mitsuhashi, S | 1 |
| Adachi, Y; Fuse, A; Hashizume, T; Kato, E; Nagano, R; Nakagawa, S; Ohtake, N; Okamoto, O; Shibata, K | 1 |
| Houchigai, H; Shinagawa, H; Sumita, Y; Sunagawa, M; Yamaga, H | 1 |
| Bowker, KE; MacGowan, AP | 2 |
| Hirata, Y; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kawaguchi, R; Kobayashi, I; Kumasaka, K; Matsuoka, K; Murakami, E; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Okamoto, E; Saeki, H; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uchida, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H | 1 |
| Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H | 1 |
| Eltahawy, AT | 1 |
| Amyes, SG | 1 |
| Papich, MG | 1 |
| Awaya, Y; Fujiue, Y; Kodomari, Y; Kuwabara, M; Muroki, K; Shimizu, S; Watanabe, Y | 1 |
| Groeneveld, PH; Kwappenberg, KM; Mattie, H; van Dissel, JT; van Langevelde, P | 1 |
| Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Ardanuy, C; Benedí, VJ; Domínguez, MA; Hernández-Allés, S; Liñares, J; Martínez-Martínez, L | 1 |
| Holbrook, KA; Lowy, FD | 1 |
| Kinoshita, S; Kumagai, S | 1 |
| Konishi, M; Maeda, K; Majima, T; Masutani, T; Mikasa, K; Mori, K; Narita, N; Sakamoto, M; Sano, R; Sawaki, M; Teramoto, S; Tsujimoto, M; Ueda, K; Yoshimoto, E | 1 |
| Oizumi, K | 1 |
| Kuroyama, M; Okamoto, E; Yago, K | 1 |
| Biedenbach, DJ; Jones, RN; Kugler, KC | 1 |
| Kanazawa, K; Nouda, H; Sumita, Y; Sunagawa, M | 1 |
| Manzor, O; Pawlak, J; Saravolatz, L | 1 |
| Alvarez-Díaz, D; Benedí, VJ; Hernández-Allés, S; Jacoby, GA; Martínez-Martínez, L; Pascual, A; Suárez, AI; Tran, J | 1 |
| Hantson, P; Léonard, F; Mahieu, P; Maloteaux, JM | 1 |
| Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
| Allerberger, F; Feierl, G; Hirschl, A; Krause, R; Mittermayer, H; Reisinger, EC; Wendelin, I | 1 |
| Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM | 1 |
| Hoogkamp-Korstanje, JA; Schouten, MA; Voss, A | 1 |
| Arita, K; Daido, K; Kohara, T; Nakamura, K; Ohashi, N; Takeshima, Y | 1 |
| Cho, JH; Jin, C; Jung, I; Kim, DH; Kim, M; Ku, HJ; Oh, CH; Yook, J | 1 |
| Kanno, O; Kawamoto, I; Miyauchi, M; Ohya, S; Shibayama, T | 1 |
| Fujimura, S; Gomi, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A; Yasui, S | 1 |
| Deguchi, K; Endo, H; Ishihara, R; Matsumoto, Y; Nishinari, C; Suzuki, Y | 1 |
| Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O | 1 |
| Bantar, C; Di Chiara, M; Nicola, F; Relloso, S; Smayevsky, J | 1 |
| Asbel, LE; Levison, ME | 1 |
| Christenson, JC; Daly, JA; Korgenski, EK | 1 |
| Nishino, T; Oh, T; Okuda, J; Otsuki, M | 1 |
| Paterson, DL | 2 |
| Aschbacher, R; De Fina, G; Lang, A; Meyer, R; Paluselli, P; Rizza, F; Zelger, P | 1 |
| Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 1 |
| Barrett, JF; Bronson, JJ | 1 |
| Stock, I; Wiedemann, B | 1 |
| Amir, J; Harel, L; Straussberg, R | 1 |
| Burgess, DS; Lewis, JS; Nathisuwan, S | 1 |
| Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C | 1 |
| Anthony, L; Appelbaum, PC; Credito, K; Ednie, LM; Hoellman, DB; Jacobs, MR; Kelly, LM | 1 |
| Avenoza, A; Busto, JH; Cativiela, C; Corzana, F; Peregrina, JM; Zurbano, MM | 1 |
| Duff, P | 1 |
| Carenbauer, AL; Crowder, MW; Garrity, JD; Periyannan, G; Yates, RB | 1 |
| Beguin, Y; Debouge, MH; Fillet, G; Frère, P; Hermanne, JP | 1 |
| Amicosante, G; Docquier, JD; Franceschini, N; Frere, JM; Galleni, M; Rival, S; Rossolini, GM; Vessillier, S | 1 |
| Akiyama, K; Endo, H; Hiramatsu, N; Jinbo, K; Koyama, T; Nishinari, C; Suzuki, Y; Tamura, C | 2 |
| Beloborodov, VB | 1 |
| Benedí, VJ; Crowley, B; Doménech-Sánchez, A | 1 |
| Nishino, T | 1 |
| Gondoh, H; Hanada, S; Ikeda, S; Imamura, Y; Izumi, Y; Kawano, F; Masuda, M; Matsuishi, E; Matsuoka, H; Okamura, S; Saburi, Y; Shibuya, T; Tamura, K; Tsukada, J; Uike, N; Utsunomiya, A | 1 |
| Biedenbach, DJ; Gales, AC; Jones, RN | 1 |
| Gudiol, F; Marín, M | 1 |
| Matsuda, H; Miwa, H; Miyazaki, S; Tsuji, M | 1 |
| Powell, LL; Wilson, SE | 1 |
| Barie, PS; Coppa, G; Cryer, HG; Fry, DE; Lee, PC; Martens, MG; Nichols, RL; O'Leary, JP; Rapp, RP; Sirinek, KR; Smith, DW; Wilson, SE | 1 |
| Majiduddin, FK; Palzkill, T | 1 |
| Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
| Leviton, I | 1 |
| Elander, RP | 1 |
| Sakamoto, M; Shiba, K | 1 |
| Nakahama, C | 1 |
| Oishi, K | 1 |
| Miyagi, K; Saito, A | 1 |
| Mikamo, H; Ninomiya, M; Tamaya, T | 1 |
| Long, TE | 1 |
| Burstein, E; Chaim, W | 1 |
| Hashimoto, K; Ito, K; Ogata, H | 1 |
| Naser, N; Shliapnikov, SA | 1 |
| Akiyama, K; Hiramatsu, N; Igari, J; Koyama, T; Oguri, T | 2 |
| Blosser-Middleton, RS; Ge, Y; Karlowsky, JA; Sahm, DF; Wikler, MA | 1 |
| Arroyo, E; Figueroa, J; González, G; Maldonado, G; Meléndez, B; Ramírez-Ronda, CH; Rodríguez-Julbe, MC; Saavedra, S | 1 |
| Barbera, J; Gerberding, JL; Hannah, E; Houck, P; Moore, JW; Samore, M; Stevenson, KB | 1 |
| Song, A | 1 |
| Gootz, TD | 1 |
| Bornand, JE; Fonseca, S; Garbino, J; Sax, H; Uçkay, I | 1 |
| Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C | 1 |
| Al Dahouk, S; Dierich, MP; Hofer, E; Neubauer, H; Splettstoesser, WD; Tomaso, H; Treu, TM | 1 |
| Chen, WH; Hsueh, PR; Luh, KT | 1 |
| Cal, RG; Castelo, A; do Carmo Filho, JR; Marra, AR; Pereira, CA; Sader, HS; Wey, SB | 1 |
| Fraser, A; Leibovici, L; Paul, M; Yahav, D | 1 |
| Abe, N; Fukuda, S; Iwasaki, M; Komatsu, M; Matsuo, S; Nagasaka, Y; Shimakawa, K | 1 |
| Dalhoff, A; Echols, R; Janjic, N | 1 |
| Baraniak, A; Bossaert, L; Demey, HE; Gniadkowski, M; Goethaert, K; Goossens, H; Ieven, M; Jansens, H; Jorens, PG; Lammens, C; Van Herck, K; Van Looveren, M | 1 |
| Owens, RC; Rice, L | 1 |
| Adukauskiene, D; Dudzevicius, V; Ryskus, L; Sakalauskas, R; Vitkauskiene, A | 1 |
| Fernández-Cuenca, F; Martínez-Martínez, L; Pascual, A; Rodríguez-Martínez, JM | 1 |
| DePestel, DD; Eschenauer, GA; Regal, RE | 1 |
| Cheng, KC; Chuang, YC; Huang, GC; Wu, LT; Yu, WL | 1 |
| Koulenti, D; Rello, J | 1 |
| Livermore, DM; Woodford, N | 1 |
| Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B | 1 |
| Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K | 1 |
| Lee, CH; Liu, JW; Su, LH; Tang, YF | 1 |
| Dahal, RK; Khadga, PK; Koirala, J; Mishra, SK; Pokharel, BM; Tuladhar, NR | 1 |
| Chai, D; Li, Z; Pei, F; Tong, W; Wang, R | 1 |
| Holzgrabe, U | 1 |
| Sendzik, J; Stahlmann, R | 1 |
| Koren, J; Vaculíková, A | 1 |
| Dalziel, C; Turner, B | 1 |
| Bronze, MS; Cooper, TW; Gibbs, WJ; Greenfield, RA | 1 |
| Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Sakata, H | 1 |
| Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA | 1 |
| Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
| Docquier, JD; Rossolini, GM | 1 |
| Coratza, G; Docquier, JD; Mantengoli, E; Musmanno, RA; Rossolini, GM | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeoung, SJ; Kim, CK; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Lee, HS; Lee, K; Song, YG; Yong, D; Yum, JH | 1 |
| Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
| Abraham, OC; Brahmadathan, KN; Jagannati, M; John, G; Kaul, S; Pitchamuthu, K; Sudarsanam, TD | 1 |
| Livermore, DM | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Falagas, ME; Vergidis, PI | 1 |
| Miyagi, T; Nakashima, T; Shigehara, K; Shimamura, M | 1 |
| Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S | 1 |
| Berkani, A; Eb, F; Mammeri, H; Nordmann, P | 1 |
| Khantipong, M; Pupaibool, J; Suankratay, C | 1 |
| Appelbaum, PC; Glupczynski, Y; Lemaire, S; Olivier, A; Tulkens, PM; Van Bambeke, F | 1 |
| Akita, H; Chiba, N; Hasegawa, K; Iwata, S; Nonoyama, M; Sato, Y; Sunakawa, K; Ubukata, K | 1 |
| Hesek, D; Lee, M; Mobashery, S; Vakulenko, SB; Villegas-Estrada, A | 1 |
| Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F | 1 |
| Koh, TH | 1 |
| French, GL | 1 |
| Haldorsen, B; Lundblad, EW; Samuelsen, O; Simonsen, GS; Sundsfjord, A | 1 |
| Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR | 1 |
| Micek, ST; Neuner, EA; Ritchie, DJ | 1 |
| Bonatti, H; Dossett, L; Fille, M; Hager, J; Sifri, CD; Stelzmueller, I | 1 |
| Ariano, RE; Bell, DD; Paunovic, B; Zarychanski, R | 1 |
| Amicosante, G; Falcone, M; Mancini, C; Mezzatesta, ML; Perilli, M; Stefani, S; Venditti, M | 1 |
| Boonkerd, N; Niumsup, PR; Pibalpakdi, P; Tiloklurs, M | 1 |
| Rice, LB | 1 |
| Crowder, MW; Fast, W; Limphong, P; Makaroff, CA; Nimako, G; Thomas, PW | 1 |
| Cheek, E; Citron, DM; Cubbon, M; Gerding, DN; Lippett, S; Llewelyn, M; Price, J; Sambol, SP | 1 |
| Ge, Y; Juan, C; Oliver, A; Pérez, JL; Zamorano, L | 1 |
| Cattoir, V; Daurel, C | 1 |
| Furuya, R; Hashimoto, J; Hashimoto, K; Hotta, H; Ichihara, K; Igarashi, M; Kurimura, Y; Miyamoto, S; Miyao, N; Tachiki, H; Taguchi, K; Takagi, Y; Takahashi, S; Takeyama, K; Tsukamoto, T; Uchida, K; Yanase, M | 1 |
| Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
| Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH | 1 |
| Carrër, A; Fortineau, N; Nordmann, P | 1 |
| Blanchard, JS; Fan, F; Tremblay, LW | 1 |
| Haruta, T; Nonoyama, M; Ouchi, K; Sakata, H; Sato, Y; Sunakawa, K; Yamaguchi, S | 1 |
| Cullik, A; Pfeifer, Y; Witte, W | 1 |
| Jiang, Y; Shen, P; Wei, Z; Yu, D; Yu, Y; Zhou, Z | 1 |
| Elborn, JS; Parkins, MD | 1 |
| Blanca, M; Torres, MJ | 1 |
| Bethel, CR; Bonomo, RA; Hornick, JM; Hujer, KM; Papp-Wallace, KM; Taracila, M; Wallace, CJ | 1 |
| Henprasert, A; Kiratisin, P | 1 |
| Chmielewski, M; Furman, B; Grzeszczyk, B; Kozioł, A; Staszewska-Krajewska, O | 1 |
| Bousquet, PJ; Caruso, C; Gaeta, F; Romano, A; Rumi, G; Valluzzi, RL | 1 |
| Fisher, JF; Llarrull, LI; Mobashery, S; Testero, SA | 1 |
| Medico, CJ; Walsh, P | 1 |
| Hsueh, PR; Ko, WC; Lu, JJ; Teng, LJ; Wang, FD; Wu, HY; Wu, JJ; Wu, TL | 1 |
| Appelbaum, PC; Armstrong, ES; Kosowska-Shick, K; Kubo, A; Lin, G; Pankuch, GA | 1 |
| Cabot, G; Macia, MD; Martínez-Martínez, L; Moya, B; Ocampo-Sosa, AA; Oliver, A; Peña, C; Rodríguez, C; Suárez, C; Tubau, F; Zamorano, L | 1 |
| Bassetti, M; Ginocchio, F; Mikulska, M | 1 |
| Bergerová, T; Hrabák, J; Urbásková, P; Zemlicková, H | 1 |
| Bordon, JM; Clark, RB; Karlowsky, JA; Master, RN; Ramirez, J | 1 |
| De Smet, B; Jacobs, J; Kham, C; Koole, O; Kruy, L; Lynen, L; Phe, T; Thai, S; Veng, CH; Vlieghe, E | 1 |
| Parta, M | 1 |
| Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
| Hornsey, M; Phee, L; Wareham, DW | 1 |
| Haug, JB; Myhr, R; Reikvam, A | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A | 1 |
| Dahyot, S; Mammeri, H | 1 |
| Boulanger, AE; Nordmann, P; Poirel, L | 1 |
| Borra, PS; El Salabi, A; Samuelsen, Ø; Toleman, MA; Walsh, TR | 1 |
| González, LJ; Vila, AJ | 1 |
| Adnan, S; Kumar, S; Li, J; Lipman, J; Paterson, DL; Roberts, JA; Rudd, M | 1 |
| De Jesús, A; Hernández, L; Marcano, D; Torres, L | 1 |
| Balan, G; Ho, WS; Koh, XP; Kong, BH; Lim, KT; Puthucheary, S; Tan, LK; Thong, KL; Yeo, CC | 1 |
| Cheong, HS; Chung, DR; Kang, CI; Ko, KS; Peck, KR; Song, JH | 1 |
| De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA | 1 |
| Abdelaziz, MO; Aleo, A; Bonura, C; El-Domany, RA; Fasciana, T; Mammina, C | 1 |
| Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH | 1 |
| Arthur, M; Dubée, V; Dubost, L; Ethève-Quelquejeu, M; Gutmann, L; Hugonnet, JE; Mainardi, JL; Marie, A; Triboulet, S | 1 |
| Hawkey, PM; Livermore, DM | 1 |
| Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
| Maheshwari, G; Singh, DK | 1 |
| Antunes, NT; Frase, H; Lamoureaux, TL; Vakulenko, SB | 1 |
| Bebrone, C; Bennink, S; Bogaerts, P; Delbrück, H; Galleni, M; Glupczynski, Y; Hoffmann, KM; Kupper, MB; Rezende de Castro, R | 1 |
| Altouvas, G; Mamali, V; Pitiriga, V; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Tziraki, M; Zarkotou, O | 1 |
| Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
| Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohta, K; Ohyashiki, K; Suzuki, K; Tamura, K; Urabe, A | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Chan, JF; Cheng, VC; Ho, PL; Lo, WU; To, KK; Tse, H | 1 |
| Kondratenko, PG; Shirshov, IV | 1 |
| Chiba, N; Morozumi, M; Ubukata, K | 1 |
| Braykov, NP; Eber, MR; Klein, EY; Laxminarayan, R; Morgan, DJ | 1 |
| Bettiol, M; Corso, A; De Belder, D; Faccone, D; Gatti, B; Gomez, S; Pasteran, F; Petroni, A; Rapoport, M; Veliz, O | 1 |
| Berendsen, BJ; Gerritsen, HW; Lameris, S; Nielen, MW; Stolker, AA; van Sebille, R; Wegh, RS | 1 |
| Bou, G; Fernández, A; Higgins, PG; Pérez-Llarena, FJ; Seifert, H; Zander, E | 1 |
| Chen, JH; He, YQ; Liu, S; Wan, YF; Xu, CQ; Ye, ML; Zheng, YL; Zhou, LY | 1 |
| Karpiuk, I; Tyski, S | 1 |
| Bonnin, RA; Nordmann, P; Poirel, L | 1 |
| Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW | 1 |
| Aitken, SL; Altshuler, J; Arias, CA; Esaian, D; Guervil, D; Papadopoulos, J | 1 |
| Goff, DA; Nicolau, DP | 1 |
| King, DT; Strynadka, NC | 1 |
| Bonomo, RA; June, CM; Kaitany, KC; Klinger, NV; Leonard, DA; Powers, RA; Ramey, ME | 1 |
| Baserni, MN; Jugo, MB; Villar, HE | 1 |
| Chen, H; Li, H; Wang, H; Wang, Q; Wang, Z; Zhang, F; Zhao, C | 1 |
| Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN | 1 |
| Chen, Z; Kang, M; Li, D; Tao, C; Wang, T; Xie, Y | 1 |
| Chan, JF; Chen, JH; Cheng, VC; Ho, PL; Kwan, GS; Tai, JW; To, KK; Tse, H; Wong, SC; Yan, MK; Yuen, KY | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Huang, M; Shao, HF; Shi, LN; Wang, WP; Wang, Y; Zeng, ZR | 1 |
| Nobari, S; Rahmati Ghezelgeh, F; Shahcheraghi, F; Valizadeh, B | 1 |
| Chen, R; Chen, Y; Guo, L; Han, L; Han, X; Luo, Y; Tian, S; Yang, J; Ye, L; Zhao, J; Zhao, Q | 1 |
| Anbarasu, A; Kumar, KM; Ramaiah, S | 1 |
| Chiu, CH; Chung, WH; Hu, HC; Huang, CT; Hung, SI; Kao, KC; Lin, JY; Lin, YF; Rosaline Hui, CY; Sindy, H; Tsai, YC; Wu, TS; Yang, CH | 1 |
| Baghdady, N; Ferraro, MJ; Galar, A; Guzmán-Suarez, BB; Hooper, DC; Kubiak, DW; Marty, FM; O'Brien, TF; Siedner, MJ | 1 |
| Doi, Y; Qureshi, ZA | 1 |
| Hall, RM; Harmer, CJ | 1 |
| Kirikae, T; Miyoshi-Akiyama, T; Narahara, K; Ohmagari, N; Shimojima, M; Tada, T; Tanaka, M; Tojo, M | 1 |
| Chandran, SP; Diwan, V; Joseph, BV; Lundborg, CS; Macaden, R; Mundayoor, S; Rosales-Klintz, S; Tamhankar, AJ | 1 |
| Chen, S; Chiou, J; Leung, TY | 1 |
| Wu, H; Xie, W; Ye, Z; Zhang, W; Zhao, C | 1 |
| Axelrod, P; Gallagher, JC; Haynes, K; Kuriakose, S | 1 |
| Chang, M; Fishovitz, J; Hermoso, JA; Mobashery, S | 1 |
| Djordjevic, G; Kula, B; Robinson, JL | 1 |
| Gallagher, JC; Terico, AT | 1 |
| Endo, S; Hidaka, H; Kaku, M; Kakuta, R; Kanamori, H; Katori, Y; Komatsu, M; Ozawa, D; Yano, H | 1 |
| Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X | 1 |
| Hong, MK; Jeon, JH; Jo, JY; Kang, LW; Karim, AM; Kim, JH; Ko, KS; Lee, JH; Lee, JJ; Lee, SH; Park, KS | 1 |
| Alfizah, H; Biglari, S; Rahman, MM; Ramliza, R | 1 |
| Achkar, M; Charrouf, FO; Dabboussia, F; Hamze, M; Mallat, H | 1 |
| Cai, X; Chai, H; Chu, C; Liu, R; Palasota, JA; Yin, W | 1 |
| Borgianni, L; Chong, Y; De Luca, F; Docquier, JD; Rossolini, GM; Thaller, MC | 1 |
| Bjerga, GE; Edvardsen, KS; Leiros, HK; Samuelsen, Ø | 1 |
| Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lam, C; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
| Dubberke, ER; Olsen, MA; Reske, KA; Yan, Y; Zilberberg, M | 1 |
| Baliga, C; D'Angeli, M; Duchin, J; Eckmann, K; Gluck, M; Kang, MG; Kay, M; Ross, AS; Swoveland, J; Verma, P; Weissman, SJ; Wendorf, KA | 1 |
| Carlson, EE; Kocaoglu, O; Tsui, HC; Winkler, ME | 1 |
| Dortet, L; Jeannot, K; Naas, T; Nordmann, P; Oueslati, S; Tandé, D | 1 |
| Chow, DC; Fryszczyn, B; Hu, L; Nordmann, P; Palzkill, T; Poirel, L; Prasad, BV; Sankaran, B; Stojanoski, V | 1 |
| Bharat, A; Demczuk, W; Martin, I; Mulvey, MR | 1 |
| Rutala, WA; Weber, DJ | 1 |
| Cai, X; Chai, H; Cheng, L; Chu, C; Guo, R; Liu, R; Palasota, JA; Yin, W | 1 |
| Almeida, LG; Gales, AC; Marcondes, MF; Martins, WM; Nicolás, MF; Nicoletti, AG; Oliveira, V; Vasconcelos, AT | 1 |
| Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
| Blaszczyk, AJ; Booker, SJ; Buller, AR; Grove, TL; Lloyd, EP; Marous, DR; Moshos, KA; Townsend, CA | 1 |
| Barajas-Nava, LA; Bonfill Cosp, X; Gianneo, OD; Lipsky, BA; Selva Olid, A; Solà, I | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Bethel, CR; Bonomo, RA; Doi, Y; Endimiani, A; Kasraian, S; Pires, J; Sendi, P; Taracila, M; Tinguely, R | 1 |
| Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
| Abdile, AA; Doi, Y; Harris, PN; Huh, K; Huxley, RR; O'Neal, CS; Pandeya, N; Paterson, DL; Paynter, S; Shen, AW; Talbot, TR; Wei, JY | 1 |
| Ito, A; Ito-Horiyama, T; Kohira, N; Nakamura, R; Rittenhouse, S; Sato, T; Tsuji, M; West, J; Yamano, Y | 1 |
| Bortolaia, V; Docquier, JD; Guardabassi, L; Gudeta, DD; Pollini, S; Rossolini, GM | 1 |
| Bellissant, E; Fillâtre, P; Flecher, E; Lemaitre, F; Leven, C; Maillard, N; Nesseler, N; Tattevin, P; Tron, C; Verdier, MC | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Srinivas, NR | 1 |
| Bonomo, RA; Caselli, E; Krishnan, NP; Nguyen, NQ; Prati, F; Rojas, LJ; Romagnoli, C; van den Akker, F | 1 |
| Blázquez, J; Cabot, G; Juan, C; Moyà, B; Navas, A; Oliver, A; Zamorano, L | 1 |
| Boyd, D; Carpenter, M; Desruisseau, A; Janecko, N; Mangat, CS; Martz, SL; Mulvey, MR; Reid-Smith, RJ | 1 |
| Damer, KM; Roman, C; Solh, T | 1 |
| Akiba, M; Bairy, I; Balakrishna, K; Fujii, Y; Guruge, KS; Iwata, T; Joshua, DI; Krishnan, P; Kuroda, M; Kusumoto, M; Lee, K; Munuswamy, N; Murata, M; Sekizuka, T; Sinha, RK; Subramanian, K; Yamashita, A | 1 |
| Gurevich, KG; Shulakova, OA; Zyryanov, SK | 1 |
| Estes, LL; Narayanan, PP; Patel, R; Rivera, CG | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Cicek, AC; Duzgun, AO; June, CM; Leonard, DA; Sandalli, C; Saral, A | 1 |
| Dissaneevate, S; Janjindamai, W; Kritsaneepaiboon, S; Maneenil, G; Tanaanantarak, P; Techato, C; Thatrimontrichai, A | 1 |
| Higuchi, H; Horikoshi, Y; Isogai, M; Ito, K; Shoji, T; Suwa, J | 1 |
| Bradford, PA; Bush, K | 1 |
| Betts, J; Liakopoulos, A; Mevius, D; Oikonomou, O; Phee, LM; Wareham, DW | 1 |
| Buschiazzo, A; Drusin, SI; Larrieux, N; Lisa, MN; Morán-Barrio, J; Moreno, DM; Viale, AM; Vila, AJ | 1 |
| Chalhoub, H; Denis, O; Deplano, A; Elborn, JS; Kahl, BC; Mustafa, MH; Rodriguez-Villalobos, H; Traore, H; Tulkens, PM; Tunney, MM; Van Bambeke, F; Vanderbist, F; Vergison, A | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Cabot, G; Domínguez, MÁ; Juan, C; López-Causapé, C; Martínez-Martínez, L; Moyà, B; Ocampo-Sosa, AA; Oliver, A; Peña, C; Plesiat, P; Rodríguez, C; Sommer, LM; Tubau, F; Zamorano, L | 1 |
| Chen, W; Liu, L; Lu, X; Zhang, K; Zhu, C | 1 |
| Gould, IM; Lawes, T; Lopez-Lozano, JM; Macartney, G; Nebot, CA; Sinclair, C; Subbarao-Sharma, R; Wares, KD | 1 |
| Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM | 1 |
| Biglari, S; Hanafiah, A; Lopes, BS; Mohd Puzi, S; Rahman, M; Ramli, R | 1 |
| Boisson, MN; Boulouis, HJ; Haenni, M; Madec, JY; Médaille, C; Melo, LC; Saras, E | 1 |
| Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF | 1 |
| Hirai, J; Koizumi, Y; Mikamo, H; Nishiyama, N; Sakanashi, D; Suematsu, H; Sugimoto, N; Yamagishi, Y | 1 |
| Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J | 1 |
| Ahn, JY; Jang, SJ; Jeong, SH; Kim, D; Lee, CH; Lee, H; Lee, K; Yong, D | 1 |
| Alberg, T; Blix, HS; Eriksen, HM; Holen, Ø; Neteland, MI; Smith, I | 1 |
| Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH | 1 |
| Abbo, LM; Adachi, J; Aitken, SL; Araos, R; Arias, CA; Bonomo, RA; Jain, R; Lichtenberger, PN; Miller, WR; Munita, JM; Nigo, M; Perez, F; Rakita, R; Rosa, R; Shelburne, S; Shimose, LA; Tran, TT; Wanger, A | 1 |
| Li, B; Li, L; Peters, BM; Shirtliff, ME; Xie, J; Xu, Z; Yu, G | 1 |
| Falagas, ME; Legakis, NJ; Skalidis, T; Vardakas, KZ | 1 |
| D'Arcy, S; Doumith, M; Findlay, J; Hopkins, KL; Howe, R; Mather, B; Meunier, D; Mustafa, N; Pike, R; Woodford, N; Wootton, M | 1 |
| Bias, T; Biason, K; El-Beyrouty, C; Gallagher, JC; Gardner, J; Harrington, N; Heil, E; Hiles, J; Huang, V; King, M; Kuriakose, S; McCoy, D; Richards, L | 1 |
| Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ | 1 |
| Al-Ahmad, M; Rodriguez-Bouza, T | 1 |
| Hollenberg, SM; Khan, ZA | 1 |
| Fisher, K; Juang, P; Kollef, MH; Micek, ST; Trupka, T | 1 |
| Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK | 1 |
| Bialek-Davenet, S; Brisse, S; Duprilot, M; Mayer, N; Nicolas-Chanoine, MH; Pagès, JM; Vergalli, J | 1 |
| Alves, CN; Bailey, S; Chauhan, V; Cohen, KA; d'Andrea, FB; Freundlich, JS; Ginell, SL; Kumar, P; Lameira, J; Lamichhane, G; Li, SG; Silva, JRA | 1 |
| Guo, X; Han, L; Sun, J; Wang, X; Xie, L; Zhang, F; Zheng, Q | 1 |
| Altshuler, J; Fedorenko, M; Kim, SA; Paris, D | 1 |
| Chan, KF; Chen, T; He, Y; Pan, X; Zhao, Y | 1 |
| Bonten, MJM; Bootsma, MCJ; Dautzenberg, MJD; Derde, LPG; Gniadkowski, M; Gurieva, T | 1 |
| Gomez-Simmonds, A; McConville, TH; Sullivan, SB; Uhlemann, AC; Whittier, S | 1 |
| Arthur, M; Edoo, Z; Hugonnet, JE; Mainardi, JL; Sütterlin, L | 1 |
| Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK | 1 |
| Feng, H; Fleming, J; Liu, W; Liu, X; Wang, DC; Wang, S | 1 |
| Khedkar, S; Khedkar, U; Lind, F; Nerkar, SS; Odsbu, I; Orsini, N; Stålsby Lundborg, C; Tamhankar, AJ | 1 |
| Akagi, M; Fukuda, S; Higuchi, T; Hikita, Y; Jikimoto, T; Kamisako, T; Kida, K; Kita, M; Kofuku, T; Komatsu, M; Maede, T; Moro, K; Nakai, I; Nakamura, T; Nishi, I; Nishio, H; Ono, T; Oohama, M; Orita, T; Satoh, K; Shimakawa, K; Sueyoshi, N; Tanaka, Y; Tobe, T; Toda, H; Toyokawa, M; Wada, Y; Yamasaki, K | 1 |
| Alfandari, S; Bertrand, X; Dumartin, C; Gauzit, R; Gbaguidi-Haore, H; Muller, A; Péfau, M; Rogues, AM | 1 |
| Alvarez-Uria, G; Gandra, S; Laxminarayan, R; Mandal, S | 1 |
| Bruns, T; Büning, J; Fichtner-Feigl, S; Kruis, W; Maaser, C; Preiß, JC; Reuken, PA; Schmelz, R; Stallmach, A; Teich, N | 1 |
| Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y | 2 |
| Hussain, BM; Hussin, H; Phoon, HYP; Thong, KL | 1 |
| Bado, I; Caiata, L; Cordeiro, N; García-Fulgueiras, V; Outeda, M; Papa-Ezdra, R; Seija, V; Vignoli, R | 1 |
| Gandra, S; Laxminarayan, R; Logan, LK; Trett, A; Weinstein, RA | 1 |
| Bertrand, X; Bouiller, K; Bouxom, H; Fournier, D; Hocquet, D | 1 |
| Brown, AC; Capers, C; Cardo, DM; Craig, M; Edwards, J; Huang, JY; Kainer, MA; Kallen, AJ; Mahon, G; Malik, S; McDonald, LC; Patel, J; Paul, P; Shugart, A; Slayton, RB; Srinivasan, A; Walters, MS; Weiner, LM; Wilde, N; Woodworth, KR | 1 |
| Bowman, AS; Daniels, JB; Feicht, SM; Mathys, DA; Mollenkopf, DF; Stull, JW; Wittum, TE | 1 |
| Agoba, EE; Essack, SY; Govinden, U; Osei Sekyere, J; Peer, AKC | 1 |
| Dai, E; Duan, X; Fang, H; Feng, J; Gao, B; Luo, Y; Tong, Y; Wang, J; Xu, Y; Yin, Z; Zhan, Z; Zhang, Y; Zhou, D | 1 |
| Bossers, A; Brouwer, MSM; Geurts, Y; Harders, F; Mevius, DJ; Rapallini, M; Veldman, KT; Wit, B | 1 |
| Ebihara, Y; Imai, K; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Sakai, J; Taji, Y; Tarumoto, N; Watanabe, N; Yamaguchi, T | 1 |
| Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N | 1 |
| Kamps, JJAG; Lohans, CT; Rabe, P; Schofield, CJ | 1 |
| Chakraborty, T; Fritzenwanker, M; Herold, S; Imirzalioglu, C; Wagenlehner, FM; Zimmer, KP | 1 |
| Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
| Bathoorn, E; Becher, D; Bonn, F; de Jong, A; Grasso, S; Nepal, S; Otto, A; Rosema, S; Rossen, JW; Stobernack, T; van Dijl, JM; Wedema, R; Zhou, K | 1 |
| Almagor, J; Carmeli, Y; Fallach, N; Gladstone, BP; Tacconelli, E; Temkin, E | 1 |
| Chen, SL; Heng, ST; Lye, DC; Ng, TM; Wong, JGX | 1 |
| Ishibashi, N; Ito, A; Ito-Horiyama, T; Nishikawa, T; Ota, M; Sato, T; Tsuji, M; Yamano, Y | 1 |
| Chan, EW; Chen, S; Li, R; Ye, L; Zheng, Z | 1 |
| Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D | 1 |
| Bonnin, RA; Dortet, L; Gauthier, L; Golse, N; Jousset, AB; Mihaila, L; Naas, T | 1 |
| Hwang, H; Kim, B | 1 |
| Dubois, V; Jayol, A; Kieffer, N; Nordmann, P; Ortiz De La Rosa, JM; Poirel, L | 1 |
| D'Andréa, ÉD; Desbonnet, C; Garcia-Solache, M; Jakoncic, J; Lee, CW; Moon, TM; Page, R; Peti, W; Rice, LB; Soares, A | 1 |
| Hu, L; Palzkill, T; Prasad, BVV; Sankaran, B; Sun, Z | 1 |
| Goneau, L; Jarvis, M; Matukas, L; Romaschin, A; Tadros, M | 1 |
| Kanlidere, Z; Karatuna, O; Kocagöz, T | 1 |
| Chen, Y; Jiang, S; Lu, X; Shen, P; Xiao, Y; Yang, P | 2 |
| Altorf-van der Kuil, W; van Dijk, K; van Prehn, J; van Triest, MI | 1 |
| Abbara, S; Cherrier, P; Diamantis, S; Hodjat, K; Jochmans, S; Monchi, M; Pitsch, A; Vinsonneau, C | 1 |
| Naber, KG; Wagenlehner, FME | 1 |
| Antona, C; Bandi, C; Brilli, M; Comandatore, F; Dichirico, B; Gismondo, MR; Piazza, A; Ridolfo, A; Rimoldi, SG; Romeri, F | 1 |
| Abdelaziz, A; El-Ekhnawy, E; Elbanna, T; Sonbol, F | 1 |
| Bedenić, B; Drenjančević, D; Kopić, J; Presečki-Stanko, A; Talapko, J; Tomić Paradžik, M; Zarfel, G | 1 |
| Ammerman, NC; Kaushik, A; Kreiswirth, BN; Lamichhane, G; Lee, J; Martins, O; Nuermberger, EL; Parrish, NM | 1 |
| Fukushima, Y; Hiyama, Y; Masumori, N; Nakajima, C; Sato, T; Shinagawa, M; Suzuki, Y; Takahashi, S; Yokota, SI | 1 |
| Bernards, ST; de Boer, MGJ; Hendriks, BJC; Lambregts, MMC; Visser, LG | 1 |
| Adam, HJ; Domalaon, R; Golden, AR; Idowu, T; Karlowsky, JA; Lagacé-Wiens, PRS; Lawrence, CK; Lynch Iii, JP; Noreddin, A; Schweizer, F; Walkty, AJ; Wiebe, K; Zelenitsky, S; Zhanel, GG; Zhanel, MA | 1 |
| Hsu, AJ; Tamma, PD | 1 |
| Castellanos, Á; Frasquet, J; Gordon, M; Martín, M; Ramirez, P; Ruiz, J; Sánchez, MÁ; Villarreal, E | 1 |
| Almirante, B; Escolà-Vergé, L; González-López, JJ; Larrosa, N; Len, O; Los-Arcos, I; Pigrau, C; Viñado, B | 1 |
| Abboud, E; Abdallah, D; Araj, GF; Atoui, R; Awad, L; Azar, N; Balkis, MM; Daoud, Z; Feghali, R; Hamze, M; Husni, R; Irani-Hakimeh, N; Jisr, T; Karayakoupoglou, G; Matar, M; Moghnieh, R; Mokhbat, JE; Yared, N; Youssef, M | 1 |
| Aitken, E; Gould, IM; Hijazi, K; Joshi, C; Oggioni, MR; Zamudio, R | 1 |
| DePestel, DD; DeRyke, CA; Gupta, V; Merchant, S; Murray, J; Puzniak, L; Srinivasan, A; Ye, G | 1 |
| Adachi, Y; Iwata, S; Mokuno, E; Morozumi, M; Sakuma, M; Tajima, T; Ubukata, K | 1 |
| Avery, LM; Nicolau, DP; Sutherland, CA | 1 |
| Epson, E; Horwich-Scholefield, S; Rizzo, K | 1 |
| Al Saif, S; Aljohany, SM; Alshaalan, M; AlShehri, A; Balkhy, HH; El-Metwally, A; El-Saed, A; Hijazi, O | 1 |
| Bruderer, V; Greiner, M; Imkamp, F; Keller, PM; Mancini, S | 1 |
| Akova, M; Chen, T; Hua, X; Ji, S; Leptihn, S; Pi, B; Xu, Q; Yan, B; Yang, Y; Yu, Y; Zhang, L; Zhou, Z | 1 |
| Bonten, MJM; Brun-Buisson, C; Plantinga, NL; Wittekamp, BHJ | 1 |
| Campos, J; Diaz Högberg, L; Eckmanns, T; Giske, CG; Grundmann, H; Heuer, OE; Jarlier, V; Johnson, AP; Kahlmeter, G; Monen, J; Monnet, DL; Pantosti, A; Rossolini, GM; Simonsen, GS; van de Sande-Bruinsma, N; Vatopoulos, A; Żabicka, D; Žemličková, H | 1 |
| Brüggemann, RJ; de Wildt, SN; Dia, N; Hartman, SJF; Orriëns, L; Schreuder, MF | 1 |
| Avison, MB; Takebayashi, Y; Taylor, ES; Whitwam, S | 1 |
| DeShong, P; Ganapati, S; Nanayakkara, IA; Nguyen, HT; Watts, D; White, IM | 1 |
| Cotta, MO; Dulhunty, JM; Eriksson, L; Harris, P; Malacova, E; Milinovich, GJ; Vickers, ML | 1 |
| Higuita-Gutiérrez, LF; Jiménez-Quiceno, JN; Vargas-Alzate, CA | 1 |
| Ahmad Kamar, A; Chong, CW; Ngoi, ST; Teh, CSJ; Yap, PSX | 1 |
| Brenner, T; Briegel, J; Brinkmann, A; Grabein, B; Heininger, A; Hochreiter, M; Lichtenstern, C; Pletz, M; Richter, DC; Störzinger, D; Weigand, MA | 1 |
| Burnham, CD; D'Souza, AW; Dantas, G; Potter, RF; Wallace, MA; Yarbrough, ML | 1 |
| Bonomo, RA | 1 |
| Ariyasu, M; Echols, R; Nagata, TD | 1 |
| Bonnin, RA; Cotellon, G; Dortet, L; Emeraud, C; Gauthier, L; Girlich, D; Jousset, AB; Jové, T; Naas, T; Sauvadet, A | 1 |
| Brown, SM; Ferraro, J; Goodman, B; Jones, PB; Lopansri, B; Stenehjem, E; Subramanian, A; Webb, BJ | 1 |
| Adam, HJ; Baxter, M; Golden, AR; Karlowsky, JA; Lagacé-Wiens, P; Walkty, A; Zhanel, GG | 1 |
| Anandan, S; Daniel, JLK; Devanga Ragupathi, NK; Iyadurai, R; Muthuirulandi Sethuvel, DP; Mutreja, A; Neeravi, AR; Sathyendra, S; Vasudevan, K; Veeraraghavan, B | 1 |
| Chikviladze, D; Gachechiladze, K; Kobeshavidze, N; Mikeladze, M | 1 |
| Mu, X; Xu, D | 1 |
| Beckstein, O; Bonnin, RA; Dabos, L; Iorga, BI; Naas, T; Retailleau, P; Zavala, A | 1 |
| Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H | 1 |
| Gu, Z; Hu, R; Zhang, Q | 1 |
| Jorda, A; Zeitlinger, M | 1 |
| Ambalkar, S; Bhotmange, S; Biswas, R; Blanchard, AM; Draper, LA; Emes, RD; Gandhi, J; Hill, C; Jain, P; Kashyap, RS; Manke, S; Monaghan, TM; Nashine, R; Satav, A; Sloan, TJ; Stockdale, SR; Wilcox, M | 1 |
| Bonsall, TJ; Miller, CL; Wilhelm, NB | 1 |
| Adams, ER; Cuevas, LE; Edwards, T; Evans, K; Hobbs, G; Sasaki, S; Sealey, J; Teethaisong, Y; Williams, C | 1 |
| Cho, EJ; Choi, DH; Chung, SW; Jang, HJ; Jung, YJ; Kang, SH; Kim, MA; Kim, MY; Kim, SW; Kim, YJ; Lee, CH; Lee, HA; Lee, JH; Lee, JS; Lee, M; Lee, YB; Oh, H; Park, J; Park, JM; Seo, YS; Song, DS; Song, J; Yang, JM; Yoon, JH; Yoon, JS; Yu, SJ | 1 |
| Bhattacharjee, A; Bhattacharjee, M; Chanda, DD; Das, BJ; Singha, KM; Wangkheimayum, J | 1 |
| Anacker, M; Castanheira, M; Johnson, JR; Johnston, BD; Porter, SB; Snippes Vagnone, P; Thuras, P; VonBank, B; Witwer, M | 1 |
| Barnini, S; Casella, C; Falcone, M; Forfori, F; Guarracino, F; Leonildi, A; Malacarne, P; Menichetti, F; Nicastro, M; Tiseo, G; Vecchione, A | 1 |
| Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
| Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
| Heil, EL; Tamma, PD | 1 |
| Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG | 1 |
| Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
| Davis, JJ; Hernandez, RE; Hoffman, LR; Long, SW; Roch, M; Rosato, AE; Rosato, RR; Rose, WE; Saavedra, MO; Taglialegna, A; Varela, MC | 1 |
| Gao, J; Guo, JH; Song, LL; Xu, JJ | 1 |
| Allend, SO; Amaral, SC; de Freitas, SB; Ferreira, MRA; Hartwig, DD; Junior, ASV; Moreira, C; Pereira, DIB; Pruski, BB | 1 |
| Al-Delaimi, MS; Yacoob Aldosky, HY | 1 |
| Abbaszadeh, F; Baradaran, B; Dehghani, L; Hasani, A; Rezaee, MA; Samadi Kafil, H; Vahhabi, A | 1 |
| Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O | 1 |
| Chusri, S; Ontong, JC; Ozioma, NF; Voravuthikunchai, SP | 1 |
| Albers, A; Korec, D; Mathys, D; Mollenkopf, D; Parker, E; Stuever, D; Wittum, T | 1 |
| Bagheri, H; Dao, VT; Montastruc, JL; Nguyen, HA; Nguyen, KD; Vu, DH | 1 |
| Carevic, B; Carmeli, Y; Cohen-Percia, S; Fallach, N; Frenk, S; Harbarth, S; Hoffman, T; Kariv, Y; Klausner, J; Lellouche, J; Nutman, A; Temkin, E | 1 |
| Anbarasu, A; Baishya, S; Bhattacharjee, A; Choudhury, MD; Das, BJ; Deshamukhya, C; Talukdar, AD; Wangkheimayum, J | 1 |
| Adams, RJ; Ballash, GA; Barr, B; Daniels, JB; Mathys, DA; Mollenkopf, DF; Mudge, M; Whittle, A; Wittum, TE | 1 |
| Chen, SC; Ding, J; Hsu, WT; Lee, CC; Qian, F; Su, MY; Tsai, JJ; Wang, CH; Wu, HP; Yang, CC; Yang, CJ | 1 |
| Bernardi, M; Castagna, A; Castiglion, B; Ciceri, F; Clerici, D; Corti, C; Farina, F; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Mastaglio, S; Oltolini, C; Pavesi, F; Peccatori, J; Ripa, M; Scarpellini, P; Tassan Din, C | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Choby, JE; Jacob, JT; Ozturk, T; Satola, SW; Weiss, DS | 1 |
| Liang, C; Meng, G; Peng, P; Zhang, X; Zhong, L; Zhou, L | 1 |
| Ebisui, A; Goto, R; Inose, R; Ishii, S; Ishikane, M; Kawabe, A; Koizumi, R; Kusama, Y; Muraki, Y; Ohmagari, N; Yagi, T | 1 |
| Boutin, S; Fiedler, MO; Hackert, T; Heeg, K; Klein, S; Kocer, K; Mehrabi, A; Mieth, M; Nurjadi, D; Richter, D; Rupp, C; Störzinger, D; Tan, B; Weigand, MA; Zimmermann, S | 1 |
| Cho, HS; D'Souza, R; Kim, H; Lee, H; Nguyen, LP; Pinto, NA; Vu, TN; Yong, D | 1 |
| Hsueh, PR; Huang, YT; Kuo, YW; Liao, CH; Teng, LJ | 1 |
| Brink, A; Chu, CY; Coetzee, J; Dimopoulos, G; Gill, CM; Moodley, C; Nicolau, DP; Opperman, CJ; Pournaras, S; Tenover, FC; Tickler, IA; Tootla, HD; Vourli, S | 1 |
| Bhagwat, S; Joshi, P; Patel, M; Shrivastava, R | 1 |
| Kuruvilla, ME; Lynde, GC; Sexton, ME; Wiley, Z; Wolf, FA | 1 |
| Aktaş, E; Alfouzan, W; Bourassa, L; Brink, A; Burnham, CD; Canton, R; Carmeli, Y; Falcone, M; Gill, CM; Kiffer, C; Marchese, A; Martinez, O; Nicolau, DP; Pournaras, S; Seifert, H; Thabit, AK; Villegas, MV; Westblade, LF | 1 |
| Alderete, JF; Cancio, LC; Carney, BW; Cindass, R; Markelz, AE; Rizzo, JA | 1 |
| Aziz, MA; Matar, GM; Moghnieh, RA; Moussa, JA | 1 |
| Czech, M; Holubar, M; Ong'uti, S; Robilotti, E | 1 |
| Arend, LNVS; Bail, L; Ito, CAS; Nogueira, KDS; Tuon, FF | 1 |
| Alcalde-Rico, M; Arias, CA; García, P; Khan, A; Martínez, JRW; Miller, WR; Moreno, MV; Munita, JM; Olivares-Pacheco, J; Rivas, L; Rojas, P; Wozniak, A | 1 |
| Evans, CT; Fitzpatrick, MA; Patel, U; Poggensee, L; Suda, KJ; Traversa, A; Wilson, GM | 1 |
| Chakraborty, DS; Chatterjee, S; Choudhury, S; Lahiry, S | 1 |
| Caldwell, B; Hamprecht, A; Henriksen, AS; Longshaw, C; Thelen, P; Yamano, Y | 1 |
| Babić, I; Jelić, M; Kosić-Vukšić, J; Križanović, S; Maravić, A; Milaković, M; Petrić, I; Puljko, A; Udiković-Kolić, N | 1 |
| Aguilar-Chávez, Y; Chávez-Meléndez, MÁ; Delgado-Bañuelos, A; Gómez-Hernández, N; Madrigal-Beas, IM; Moras-Villela, VL; Ochoa-García, IV; Ortega-Cisneros, M | 1 |
| Byrne, D; Lai, L; Rose, L | 1 |
| Doi, Y; Echols, R; Matsunaga, Y; Nordmann, P; Shields, RK; Takemura, M; Yamano, Y | 1 |
| Albur, M; Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR | 1 |
| Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY | 1 |
| Bush, K; Carpenter, J; Chu, TY; Divoky, C; Lee-Hsiao, C; Neidig, N; Sultana, R; Threatt, H; Zhang, Q | 1 |
| Carratalà, J; Cuervo, G; González Laguna, M; Llop Talaveron, J; Padullés, A; Pérez-Recio, S; Ronda, M; Soldevila-Boixader, L; Tubau Quintano, MF | 1 |
| Cremanns, M; Gatermann, SG; Lange, F; Pfennigwerth, N | 1 |
| Barnini, S; Della Sala, L; Falcone, M; Farcomeni, A; Leonildi, A; Menichetti, F; Tiseo, G; Vecchione, A | 1 |
| Belley, A; Kaye, KS | 1 |
| Bollam, N; Chavez, MA; Gandra, S; George, I; Harbarth, S; Huttner, B; Katukoori, S; Mertz, D; Moja, L; Pulcini, C; Sayood, S; Sharland, M; Sulis, G; Tetteh, E; Yaeger, LH; Yarrabelli, S | 1 |
| Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S | 1 |
| Heil, EL; Hirsch, EB; Karaba, SM | 1 |
| Aitken, SL; Bonomo, RA; Clancy, CJ; Mathers, AJ; Tamma, PD; van Duin, D | 1 |
| Blandino-Ortiz, A; Montufar, J; Soriano, MC | 1 |
| Canton, R; Doi, Y; Simner, PJ | 1 |
| Annane, D; Bonten, MJM; Carneiro, J; Deja, M; Estevez, F; Harbarth, S; Jereb, M; Jorens, PG; Lawrence, C; Rothbart, A; Schedler, D; Seme, K; Šifrer, F; Spöhr, F; Tomič, V; van Duijn, PJ; Verbrugghe, W | 1 |
| Bonnin, RA; Dortet, L; Emeraud, C; Jousset, AB; Naas, T | 1 |
| Ju, YG; Lee, HJ; Lee, MG; Sohn, JW; Yim, HS; Yoon, YK | 1 |
| Actis, LA; Bonomo, RA; Escalante, J; Georgeos, N; Mezcord, V; Nishimura, B; Pasteran, F; Pimentel, C; Ramirez, MS; Rodriguez, C; Sieira, R; Subils, T; Tolmasky, ME; Tuttobene, MR | 1 |
| Cruz-López, F; Garza-González, E; Maldonado-Garza, HJ; Martínez-Meléndez, A; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
| Alby, K; Cowden, L; Cressman, L; Dumm, R; Glaser, L; Gross, R; Jaskowiak-Barr, A; Lautenbach, E; Mannathoko, N; Mokomane, M; Mosepele, M; Otukile, D; Paganotti, GM; Reesey, E; Richard-Greenblatt, M; Sewawa, K; Sharma, A; Smith, RM | 1 |
| Adams, RJ; Albers, AL; Ballash, GA; Dennis, PM; Li, C; Mollenkopf, DF; Robison, TL; Tyson, GH; Wittum, TE | 1 |
| Abouelhassan, Y; Bourdages, G; Gutierrez, RL; Kufel, WD; Nicolau, DP; Perwez, T; Steele, JM | 1 |
| Carvalhaes, CG; Castanheria, M; Duncan, LR; Mendes, RE; Sader, HS | 1 |
| Brenner, T; Witzke, O | 1 |
| Adams, ER; Alyayyoussi, G; Byrne, RL; Charles, M; Cocker, D; Edwards, T; Feasey, N; Hearn, J; Mandula, T; Mphasa, M; Rigby, J; Williams, CT | 1 |
| Billet, M; Boulouis, HJ; Châtre, P; Drapeau, A; Haenni, M; Lagrée, AC; Madec, JY; Va, F | 1 |
| Ashley, EA; Becker, K; Gysin, M; Haldimann, K; Hinfonthong, P; Hobbie, SN; Hon, PY; Hopkins, J; Kaewphanderm, N; Kesteman, T; Ling, CL; Nguyen, TH; Pham, TD; Roberts, T; Sengduangphachanh, A; Simmalavong, M; Simpson, AJH; Tan, P; Tran, HH; Turner, P; van Doorn, HR; Vasoo, S | 1 |
| Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
| Cayo da Silva, R; Esimone, CO; Gales, AC; Iroha, IR; Moses, IB; Ribeiro, ÁCDS; Rubin, JE; Santos, FF; Sniatynsky, MK | 1 |
| Ahmed, D; Amin, MB; Asaduzzaman, M; Hossain, MI; Islam, MA; Islam, MR; Khan, R; Rahman, M; Riley, LW | 1 |
| Guo, C; Guo, X; Huang, S; Li, M; Lv, C; Shang, J; Sun, B; Zhang, W; Zhou, N; Zhu, Y | 1 |
| Buranapraditkun, S; Chongpison, Y; Klaewsongkram, J; Mongkolpathumrat, P; Palapinyo, S; Thantiworasit, P | 1 |
| Hrynchuk, OB; Ishchak, OM; Kolesnik, AV; Rud, VO; Salmanov, AG; Terekhov, VA; Voloshynovych, NS | 1 |
| Findlay, J; Nordmann, P; Poirel, L; Rens, C | 1 |
| Bonnin, RA; Pfeifer, E; Rocha, EPC | 1 |
| Alammar, MA; Alotaibi, BS; Bandy, A; Farhana, A; Mohammed, AH; Shah, NN; Tantry, BA; Wani, F | 1 |
| Gehlot, P; P, H | 1 |
| Cabañero-Navalón, MD; Garcia-Bustos, V; Salavert Lletí, M | 1 |
| Mensa, J; Soriano, A | 1 |
| Cantón, R; Castillo-Polo, JA; Gijón Cordero, D; Ruiz-Garbajosa, P | 1 |
| Maseda, E; Suárez de la Rica, A | 2 |
| Dela-Pena, J; Gavaghan, V; Miller, JL | 1 |
| Haines, RR; Hammer, KA; Putsathit, P; Tai, AS | 1 |
| Grafl, B; Hess, C; Hess, M; Maegdefrau, M | 1 |
| Abdulhemid Said, L; Muhsin, EA; Sajid Al-Jubori, S | 1 |
| Acampora, A; Albano, R; Buonsenso, D; Ferrari, V; Fiori, B; Pata, D; Sanguinetti, M; Spanu, T; Valentini, P | 1 |
| Bassetti, M; Castaldo, N; Giacobbe, DR; Grossi, PA; Peghin, M; Vena, A | 1 |
| Gill, CM; Nicolau, DP | 1 |
| Bonomo, RA; Corso, A; Mezcord, V; Pasteran, F; Ramirez, MS; Tolmasky, ME; Wong, O | 1 |
| Alalwan, B; Alghoribi, MF; Aljohani, S; Alreheli, A; Alzayer, M; Bosaeed, M; Doumith, M | 1 |
| Bacci, C; Bonardi, S; Cabassi, CS; Cavirani, S; Conter, M; Crippa, C; Fiaccadori, E; Filippin, N; Gambi, L; Iannarelli, M; Lamperti, L; Marra, F; Paladini, C; Parisi, A; Pasquali, F; Rega, M; Spadini, C | 1 |
| Beisken, S; Bergman, Y; Conzemius, R; Jacobs, EB; Lewis, S; Materna, A; Simner, PJ; Tamma, PD; Weinberger, J; Weinmaier, T | 1 |
| Christaki, E; Cross, ELA; Del Toro, MD; Eckmann, C; Friedrich, AW; Giannella, M; Guirao, X; Kluytmans, J; Mutters, NT; Presterl, E; Righi, E; Sganga, G; Tacconelli, E; Tsioutis, C; Visentin, A | 1 |
| Chen, J; Ding, X; Du, B; Gao, S; Hu, Y; Liu, D; Ma, D; Ma, L; Ma, X; Meng, X; Shan, G; Su, L; Sun, G; Zhang, F; Zhou, X; Zhu, W | 1 |
| Bi, M; Chen, W; Dong, X; Gao, Y; He, H; Hou, S; Ji, H; Jia, Y; Li, H; Li, J; Li, Z; Liu, G; Niu, S; Wang, X; Yang, Z; Yao, G; Yu, Y; Zhang, J; Zhang, Y; Zhao, G; Zhu, R | 1 |
| Bogaerts, P; Bonnin, RA; Dabos, L; Dortet, L; Girlich, D; Glupczynski, Y; Iorga, BI; Jaskólski, M; Naas, T; Peyrat, A; Raczynska, JE; Retailleau, P; Zavala, A | 1 |
| Gatti, M; Pea, F | 1 |
| Carvalho, TN; Deglmann, RC; França, PHC; Hille, D; Kobs, VC; Melo, LH | 1 |
| Jian, C; Li, Y; Ni, M; Ning, Q; Song, J; Tian, F; Wang, Y; Yu, B | 1 |
| Barchia, I; Karmila, A; Ramandati, A; Zhang, L | 1 |
| Hsieh, PC; Hsueh, PR; Jean, SS; Kuo, DH; Liu, IM; Liu, YL | 1 |
| Dai, Y; Lei, T; Li, P; Luo, H; Yang, Z; Zhou, Y; Zhu, D | 1 |
| Bogiel, T; Grabowska, M; Sękowska, A | 1 |
| Allel, K; Day, L; Furuya-Kanamori, L; Hamilton, A; Laxminarayan, R; Lin, L; Moore, CE; Van Boeckel, T; Yakob, L | 1 |
| Bercot, B; Bernier, J; Bleibtreu, A; Chaibi, K; Contejean, A; Cuzon, G; Delory, T; El Alaoui, F; Escaut, L; Joseph, A; Lafaurie, M; Maillard, A; Molina, JM; Paccoud, O; Poupet, H; Robert, J; Surgers, L; Tankovic, J; Villa, A | 1 |
| Carmona, P; Córdoba-Fernández, M; de la Fuente, C; Domínguez, A; García, L; Guzmán-Puche, J; López-Viñau, T; Machuca, I; Martínez-Martínez, L; Merino, N; Robles, JC; Rodríguez, M; Torre-Cisneros, J; Vaquero, JM | 1 |
| Blanco-Martín, T; Cantón, R; Gasca-Santiyán, M; Guzmán-Puche, J; Hernández-García, M; Herrera, C; Martínez-Martínez, L; Riazzo, C; Torre-Cisneros, J | 1 |
| Michi, Y; Okihata, R; Sunakawa, M; Tagashira, Y | 1 |
| Alonso-Garcia, I; Alvarez-Fraga, L; Arca-Suárez, J; Beceiro, A; Bou, G; González-Bello, C; Guijarro-Sánchez, P; Lasarte-Monterrubio, C; Lence, E; Maceiras, R; Martinez-Guitian, M; Outeda, M; Peña-Escolano, A; Vázquez-Ucha, JC | 1 |
| Hsueh, PR; Ko, WC; Lee, YL | 1 |
| Fujimori, T; Hagiya, H; Higashikage, A; Iio, K; Kakehi, A; Minabe, H; Okura, M; Otsuka, F; Yokoyama, Y | 1 |
| Holmes, AH; Nasomsong, W; Panuvatvanich, B; Rawson, TM; Vasikasin, V | 1 |
| Dupont, H; Echols, R; Greenberg, DE; Kollef, M; Nicolau, DP; Viale, P; Yamano, Y | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Accordini, S; Azzini, AM; Bazaj, A; Be, G; Coledan, I; Lambertenghi, L; Lo Cascio, G; Mazzaferri, F; Miotti, J; Mirandola, M; Naso, L; Salerno, ND; Tacconelli, E | 1 |
| Ayodo, C; Bollinger, S; Call, DR; Caudell, MA; Ita, T; Kariuki, S; Luvsansharav, U; Mugoh, R; Omulo, S; Palmer, GH; Ramay, BM; Smith, RM; Styczynski, A | 1 |
| Acevedo, J; Araos, R; D'Agata, EMC; Ferreccio, C; González, M; Huidobro, LA; Jara, A; Khan, A; Maureira, L; Munita, JM; Paredes, C; Park, BJ; Peters, A; Rioseco, ML; Rivas, L; Sánchez, F; Sepulveda, D; Smith, RM; Soto, PR; Spencer-Sandino, M; Styczynski, A; Undurraga, E; Usedo, P; Wettig, LR | 1 |
| Ahmed, D; Bollinger, S; Chowdhury, F; Hassan, MZ; Hossain, K; Khan, AA; Luvsansharav, UO; Mah-E-Muneer, S; Mozumder, P; Rahman, M; Sarker, M; Sen, D; Sharma, A; Smith, RM; Styczynski, A; Vanderende, D | 1 |
| Actis, LA; Bonomo, RA; Escalante, J; Mezcord, V; Nishimura, B; Pasteran, F; Ramirez, MS; Subils, T; Tolmasky, ME; Tuttobene, MR | 1 |
| Bartolini, A; Bartoloni, A; Bernardo, M; Bianco, V; Botta, A; Faragona, A; Giacometti, A; Giani, T; Graziani, L; Lagi, F; Morroni, G; Parrella, R; Piccica, M; Rossolini, GM; Spinicci, M; Tavio, M | 1 |
| Becker, K; Bohnert, JA; Bueter, A; Echelmeyer, T; Eger, E; Fickenscher, H; Guenther, S; Heiden, SE; Krumbholz, A; Maschkowitz, G; Nurjadi, D; Schaufler, K; Schwabe, M | 1 |
| Casapia, M; Concha-Velasco, F; Díaz, JC; Farnham, A; Fernández, V; Garcia, C; Guillermo, R; Krapp, F; Kuenzli, E; Machaca, I; Olivera, M; Rondon, C; Sarmiento, F; Sutter, ST; Vilcapoma, P; Villegas, M | 1 |
| Cantón, R; Ruiz-Garbajosa, P | 1 |
111 review(s) available for carbapenems and cephalosporin c
| Article | Year |
|---|---|
An overview of antimicrobial therapy.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Humans; Macrolides; Microbial Sensitivity Tests; Monobactams; Penicillins; Sulfonamides; Vancomycin | 1992 |
Antibiotic choices in surgical intensive care unit patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Carbapenems; Cephalosporins; Critical Care; Drug Resistance, Microbial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monobactams; Mycoses; Penicillins; Pneumonia; Surgical Wound Infection; Vancomycin | 1991 |
Role of newer antimicrobial agents in the treatment of mixed aerobic and anaerobic infections.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bacteroides Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Therapy, Combination; Humans; Penicillins; Streptococcal Infections | 1991 |
Antibacterial therapy: problems and promises, Part I.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Monobactams | 1990 |
The febrile neutropenic patient: newer options for empirical therapy.
Topics: Agranulocytosis; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Neutropenia; Quinolones | 1990 |
Dual-action antibiotic hybrids.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Fluoroquinolones; Structure-Activity Relationship | 1994 |
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin | 1996 |
Pharmacodynamics of antimicrobial agents and rationale for their dosing.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Drug Administration Schedule; Glycopeptides; Humans; Microbial Sensitivity Tests; Penicillins | 1997 |
Antibacterial drug therapy. Focus on new drugs.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Fluoroquinolones; Glycopeptides; Macrolides; Penicillins | 1998 |
Beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Communicable Diseases; Humans; Penicillins | 1998 |
Continuous infusion of beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Monobactams; Penicillins; Time Factors | 1998 |
[Advances in anti-infective agents and methods for their application].
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Humans; Macrolides | 1998 |
[A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci].
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Aerobic Rods and Cocci; Gram-Positive Cocci; Humans; Japan; Macrolides; Monobactams; Penicillin Resistance; Penicillins; Tetracycline Resistance; Tetracyclines | 1998 |
How epileptogenic are the recent antibiotics?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Brain; Carbapenems; Cephalosporins; Epilepsy; Fluoroquinolones; Humans; Monobactams; Receptors, GABA; Risk Assessment; Risk Factors; Seizures; Structure-Activity Relationship; Synaptic Transmission | 1999 |
Cephalosporins, carbapenems, and monobactams.
Topics: Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Monobactams | 2000 |
[Resistance and new antibiotic strategies. New antistaphylococcal antibiotics].
Topics: Anti-Infective Agents; Carbapenems; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Fluoroquinolones; Humans; Methicillin Resistance; Staphylococcal Infections; Virginiamycin | 2000 |
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2000 |
Quinolone, everninomycin, glycylcycline, carbapenem, lipopeptide and cephem antibacterials in clinical development.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Clinical Trials as Topic; Daptomycin; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Minocycline; Prodrugs; Tetracyclines; Tigecycline | 2001 |
Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Microbial Sensitivity Tests; Risk Factors | 2001 |
Antibiotic selection in obstetrics: making cost-effective choices.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
[A choice of antibacterial chemotherapy for nosocomial infections caused by pathogens producing broad-spectrum beta-lactamases].
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cross Infection; Humans | 2001 |
[Recent trend for the development of new antibacterial agents].
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Drug Design; Drug Resistance, Multiple, Bacterial; Humans; Macrolides | 2002 |
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
Separating fact from fiction: the data behind allergies and side effects caused by penicillins, cephalosporins, and carbapenem antibiotics.
Topics: Animals; Carbapenems; Cephalosporins; Drug Hypersensitivity; Humans; Penicillins | 2003 |
Industrial production of beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Biotechnology; Carbapenems; Cephalosporins; Cephamycins; Clavulanic Acid; Drug Industry; Fermentation; Penicillins | 2003 |
[Nephrotoxicity of anti-infective agents].
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Kidney Diseases; Penicillins; Peptides | 2003 |
[Klebsiella infection].
Topics: 4-Quinolones; Anti-Infective Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillinase; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 2003 |
[Pseudomonas aeruginosa infection].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Biofilms; Carbapenems; Cephalosporins; Fimbriae, Bacterial; Flagella; Humans; Immunocompromised Host; Multidrug Resistance-Associated Proteins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Trans-Activators; Urinary Tract Infections | 2003 |
[Melioidosis].
Topics: 4-Quinolones; Anti-Infective Agents; Burkholderia pseudomallei; Carbapenems; Cephalosporins; Diagnosis, Differential; Drug Resistance, Bacterial; Humans; Melioidosis | 2003 |
[Anaerobic abscess].
Topics: Abscess; Bacteria, Anaerobic; Carbapenems; Cephalosporins; Diagnosis, Differential; Drug Therapy, Combination; Humans; Prognosis | 2003 |
Recent progress toward the clinical development of new anti-MRSA antibiotics.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Coumarins; Humans; Methicillin Resistance; Oxazoles; Peptides; Staphylococcus aureus | 2003 |
Postpartum infection treatments: a review.
Topics: 4-Quinolones; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clindamycin; Endometritis; Female; Humans; Mastitis; Metronidazole; Penicillins; Postpartum Period; Thrombophlebitis | 2003 |
[Surgical infection of soft tissue--a problem of adequate antibiotic therapy].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Diabetic Foot; Drug Therapy, Combination; Fasciitis, Necrotizing; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Soft Tissue Infections; Species Specificity; Surgical Wound Infection | 2003 |
Antibiotics in older adults.
Topics: Age Factors; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Interactions; Fluoroquinolones; Humans; Macrolides; Monobactams; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Structure-Activity Relationship | 2004 |
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enzyme Inhibitors; Fever; Humans; Neutropenia; Penicillanic Acid; Penicillins; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome | 2006 |
Redefining penems.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Structure; Penicillins | 2006 |
Hospital-based strategies for combating resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Infection Control | 2006 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
Topics: Acinetobacter; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Plasmids; Pseudomonas | 2006 |
[Structure-activity relationships of penicillin G to tricyclic beta-lactams].
Topics: Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Humans; Penicillin G; Penicillins; Structure-Activity Relationship | 2006 |
[Opposition to Ehrlich's paradigm of selective toxicity. Adverse effects of beta lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Diarrhea; Drug Hypersensitivity; Enterocolitis, Pseudomembranous; Humans; Monobactams; Penicillins | 2006 |
[Development of Beta-lactamase resistance in enterobacteria].
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 2006 |
Part II. Introduction to the beta-lactam antibiotics.
Topics: Administration, Oral; Anaphylaxis; Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cross Reactions; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Monobactams; Penicillins; Skin Tests; Time Factors | 2006 |
New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.
Topics: Bacteria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Evolution, Molecular; Mutation | 2006 |
Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; North America | 2007 |
Defining an extended-spectrum beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Escherichia coli; Gram-Negative Bacteria; Kinetics; Microbial Sensitivity Tests; Mutation | 2008 |
Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.
Topics: Animals; Carbapenems; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Glycylglycine; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxins | 2008 |
Gram-negative resistance in Singapore: a historical perspective.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; History, 20th Century; History, 21st Century; Humans; Microbial Sensitivity Tests; Quinolones; Singapore | 2008 |
What's new and not so new on the antimicrobial horizon?
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Pyrimidines; Research | 2008 |
[Broad-spectrum beta-lactamases in Gram-negative bacteria].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Penicillins; Plasmids | 2008 |
Addressing the challenge of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections | 2009 |
New antibiotics for healthcare-associated pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin | 2009 |
The clinical consequences of antimicrobial resistance.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa | 2009 |
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Gram-Negative Bacteria; Humans | 2010 |
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline | 2010 |
The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Clavulanic Acids; Cross Reactions; Drug Hypersensitivity; Humans; Monobactams; Penicillins; Risk Factors; Skin Tests | 2010 |
The future of the β-lactams.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Monobactams | 2010 |
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
New treatment options against gram-negative organisms.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Resistance, Multiple; Drugs, Investigational; Gram-Negative Bacterial Infections; Humans; United States | 2011 |
Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Diffusion; Drainage; Humans; Intraabdominal Infections; Metabolic Clearance Rate; Penicillins | 2012 |
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression; Gene Transfer, Horizontal; Humans; Minocycline; Mutation; Tigecycline | 2013 |
Targeting metallo-β-lactamase enzymes in antibiotic resistance.
Topics: Aptamers, Nucleotide; Bacteria; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Catalytic Domain; Cephalosporins; Cyclobutanes; Enzyme Inhibitors; Humans; Penicillins; Sulfhydryl Compounds | 2013 |
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
Topics: Allosteric Regulation; beta-Lactams; Carbapenems; Cell Wall; Cephalosporins; Cross-Linking Reagents; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Structure; Penicillin-Binding Proteins; Penicillins; Peptide Synthases | 2014 |
A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Male; Middle Aged; Penicillins; Young Adult | 2014 |
Beta-lactam hypersensitivity and cross-reactivity.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Monobactams; Penicillins | 2014 |
Systemic antibiotics for treating diabetic foot infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Diabetic Foot; Fluoroquinolones; Humans; Penicillins; Randomized Controlled Trials as Topic | 2015 |
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae Infections; Humans; Quinolones; Serratia Infections; Survival Analysis; Treatment Outcome | 2016 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
β-Lactams and β-Lactamase Inhibitors: An Overview.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; History, 20th Century; History, 21st Century; Humans; Monobactams; Penicillins | 2016 |
Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Erythromycin; Hospitalization; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Serogroup; Serotyping; Streptococcus pneumoniae; Treatment Outcome | 2017 |
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
Roles of 2-oxoglutarate oxygenases and isopenicillin N synthase in β-lactam biosynthesis.
Topics: beta-Lactams; Carbapenems; Cephalosporins; Ketoglutaric Acids; Mixed Function Oxygenases; Oxidoreductases; Oxygenases | 2018 |
Treatment Options for Carbapenem- Resistant Gram-Negative Infections.
Topics: Aminoglycosides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Therapy, Combination; Escherichia coli; Fluoroquinolones; Fosfomycin; Germany; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Tigecycline | 2018 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Molecular Structure; Randomized Controlled Trials as Topic; Siderophores | 2019 |
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam | 2019 |
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Topics: Acute Kidney Injury; Adolescent; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cephalosporins; Child; Child, Preschool; Critical Illness; Drug Monitoring; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Male; Penicillins; Vancomycin; Young Adult | 2020 |
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Humans; Hydrotherapy; Intensive Care Units; Penicillins; Respiration, Artificial; Risk Factors; Urinary Catheters; Vascular Access Devices | 2019 |
[Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Penicillins | 2019 |
Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Resistance, Bacterial; Europe; Humans; United States; United States Food and Drug Administration | 2019 |
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clinical Trials as Topic; Drug Development; Europe; Humans; United States; United States Food and Drug Administration | 2020 |
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
A plethora of carbapenem resistance in
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; beta-Lactams; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymyxin B; Tetracyclines | 2021 |
Optimal initial antibiotic regimen for the treatment of acute appendicitis: a systematic review and network meta-analysis with surgical intervention as the common comparator.
Topics: Adult; Anti-Bacterial Agents; Appendicitis; Carbapenems; Cephalosporins; Child; Humans; Network Meta-Analysis | 2021 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant Gram-negative bacterial pathogens in Lebanon, Jordan and Iraq.
Topics: Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Iraq; Jordan; Lebanon; Microbial Sensitivity Tests | 2021 |
Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests | 2022 |
Cefiderocol: A new Antimicrobial for Complicated Urinary Tract Infection (CUTI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Siderophores; Urinary Tract Infections | 2022 |
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrolytes; Humans; Linezolid; World Health Organization | 2022 |
Cefiderocol.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Humans | 2022 |
Treatment of carbapenem-resistant
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
Efficacy and
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Tazobactam | 2022 |
[Clinical experience using cefiderocol].
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Monobactams | 2023 |
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Tetracyclines | 2022 |
Mechanism of action of cefiderocol.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cattle; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Iron; Quinolones; Serine; Tetracyclines | 2022 |
Antibacterial spectrum of cefiderocol.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catechols; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Iron; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Siderophores | 2022 |
The role of cefiderocol in clinical practice.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2022 |
Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2022 |
Clinical evidence supporting cefiderol for serious Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2022 |
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Monobactams; Prospective Studies | 2023 |
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2023 |
Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Off-Label Use | 2023 |
Pharmacist-led multi-faceted intervention in an antimicrobial stewardship programme at a dental university hospital in Japan.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Drug Prescriptions; Fluoroquinolones; Hospitals, University; Humans; Japan; Macrolides; Penicillins; Pharmacists | 2023 |
Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: Review of the evidence.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Prospective Studies; Randomized Controlled Trials as Topic | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Treatment guidelines for multidrug-resistant Gram-negative microorganisms.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Communicable Diseases; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2023 |
14 trial(s) available for carbapenems and cephalosporin c
| Article | Year |
|---|---|
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients.
Topics: Adolescent; Adult; Carbapenems; Ceftazidime; Cephalosporins; Child, Preschool; Cystic Fibrosis; Drug Tolerance; Humans; Liver; Meropenem; Microbial Sensitivity Tests; Nausea; Pseudomonas Infections; Spirometry; Sputum; Thienamycins; Transaminases; Treatment Outcome; Vomiting | 1995 |
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins | 1995 |
[Comparative study on the efficacy of ritipenem acoxil and cefotiam hexetil in chronic lower respiratory tract infections by the double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Carbapenems; Cefotiam; Cephalosporins; Chronic Disease; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Respiratory Tract Infections | 1996 |
[Clinical evaluation of lung abscess diagnosed by transtracheal aspiration].
Topics: Adult; Aged; Bacteria, Aerobic; Bacteria, Anaerobic; Bacteriological Techniques; Carbapenems; Cephalosporins; Female; Humans; Lung Abscess; Male; Middle Aged; Suction | 1998 |
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
Topics: Adult; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Neutropenia | 2002 |
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Treatment Failure; Treatment Outcome | 2006 |
Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Female; Fever; Hematologic Diseases; Humans; Male; Meropenem; Neutropenia; Prospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2013 |
The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Cross-Over Studies; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Gram-Negative Bacteria; Humans; Intensive Care Units; Male; Middle Aged; Mouthwashes | 2020 |
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult | 2021 |
Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Escherichia coli; Humans; Microbial Sensitivity Tests | 2022 |
The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross-Over Studies; Gram-Negative Bacteria; Humans; Intensive Care Units; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Tazobactam | 2022 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
434 other study(ies) available for carbapenems and cephalosporin c
| Article | Year |
|---|---|
A comparative study on the convulsant activity of carbapenems and beta-lactams.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Receptors, GABA-A; Seizures; Synaptic Membranes | 1992 |
[Multiply resistant Pseudomonas aeruginosa in the pediatric field].
Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Monobactams; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 1991 |
[Development of antibiotherapy and new trends].
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Therapy; Humans; Macrolides; Monobactams; Quinolones | 1990 |
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
Topics: Bacteria; beta-Lactamases; Carbapenems; Cefpirome; Ceftazidime; Cephalosporins; Humans; Imipenem; Molecular Structure; Thienamycins | 1990 |
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
Topics: beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Escherichia coli; Klebsiella; Microbial Sensitivity Tests | 1989 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1989 |
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Ceftibuten; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Respiratory Tract Infections | 1989 |
Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins.
Topics: Acylation; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Kinetics; Meropenem; Thienamycins | 1989 |
The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Thienamycins | 1985 |
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cloxacillin; Enzyme Inhibitors; Humans; Indicators and Reagents; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa | 1995 |
Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and beta-lactamase producing bacteria.
Topics: Bacteria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Regulation of beta-lactamase induction in gram-negative bacteria: a key to understanding the resistance puzzle.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple; Gene Expression Regulation, Enzymologic; Gram-Negative Bacteria; Monobactams; Penicillins | 1994 |
The in vitro activity of FCE 22101 against gram-negative aerobic isolates resistant to third generation cephalosporins.
Topics: Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Humans; Microbial Sensitivity Tests | 1994 |
Efficacy of meropenem in experimental meningitis.
Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins | 1995 |
[In vitro antibacterial activities of carbapenems and other antibiotics against Pseudomonas aeruginosa determined using low-amino-acid agar].
Topics: Agar; Amino Acids; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Culture Media; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1995 |
Comparative in vitro activity of furopenem against aerobic bacteria isolated from pediatric patients.
Topics: Bacteria, Aerobic; Carbapenems; Cephalosporins; Child, Preschool; Humans; Microbial Sensitivity Tests; Penicillins | 1995 |
[In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams].
Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporinase; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Hospital Units; In Vitro Techniques; Monobactams; Pseudomonas aeruginosa | 1996 |
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Tazobactam | 1996 |
Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.
Topics: Carbapenems; Ceftazidime; Cephalosporins; Endotoxins; Imipenem; Lipopolysaccharides; Lymphotoxin-alpha; Meropenem; Nitric Oxide; Pseudomonas aeruginosa; Thienamycins; Tumor Necrosis Factor-alpha | 1996 |
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1996 |
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Hydrolysis; Imipenem; Kinetics; Mutation | 1997 |
In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
Topics: Animals; Carbapenems; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Imipenem; In Vitro Techniques; Male; Meropenem; Mice; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1997 |
Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Dipeptidases; Humans; Magnetic Resonance Spectroscopy; Methicillin Resistance; Microbial Sensitivity Tests; Models, Chemical; Models, Molecular; Protein Binding; Serum Albumin; Staphylococcus aureus; Structure-Activity Relationship | 1997 |
[Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1997 |
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins | 1997 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
Strategies and options for minimizing resistance emergence in pulmonary infections.
Topics: Acinetobacter; Anti-Infective Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Hospitals; Humans; Lung Diseases; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Scotland; Streptococcus pneumoniae | 1998 |
[The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serotyping; Sputum; Thienamycins | 1998 |
Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Ceftazidime; Cephalosporins; Galactose; Hexosyltransferases; Imipenem; Lipopolysaccharides; Membranes; Microbial Sensitivity Tests; Models, Biological; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Salmonella typhi; Time Factors | 1998 |
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1998 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
Topics: Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Cephamycins; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Spain | 1998 |
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins | 1998 |
Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 1999 |
Structure-activity relationships of carbapenems to the antagonism of the antipseudomonal activity of other beta-lactam agents and to the beta-lactamase inducibility in Pseudomonas aeruginosa: effects of 1beta-methyl group and C-2 side chain.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Enzyme Induction; Methylation; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Structure-Activity Relationship | 1999 |
In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Glycopeptides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Streptococcus pneumoniae | 1999 |
Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 1999 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Topics: Acinetobacter; Anti-Bacterial Agents; Austria; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonadaceae; Tazobactam; Thienamycins | 1999 |
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden | 1999 |
Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.
Topics: Anti-Bacterial Agents; Carbapenems; Cefpirome; Cephalosporins; Chloramphenicol; Enterococcus faecalis; Enterococcus faecium; Europe; Fluoroquinolones; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins | 1999 |
[Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; beta-Lactam Resistance; Carbapenems; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Ofloxacin; Pseudomonas aeruginosa; Thienamycins | 1999 |
Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners.
Topics: Animals; Carbapenems; Cefazolin; Cephalosporins; GABA Agonists; Imipenem; Injections, Intraventricular; Male; Meropenem; Mice; Mice, Inbred ICR; Muscimol; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Seizures; Synaptic Membranes; Thienamycins | 1999 |
Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Carbapenems; Cefdinir; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Half-Life; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Stereoisomerism; Structure-Activity Relationship | 1999 |
[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
Topics: Bacteria; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Penicillins; Piperacillin; Respiratory Tract Infections; Thienamycins; Time Factors | 1999 |
[Antimicrobial activities of meropenem against clinically isolated strains in 1997].
Topics: Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Thienamycins; Time Factors | 1999 |
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate | 2000 |
Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2000 |
In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 2000 |
In vitro activity of DU-6681a, an active form of the new oral carbapenem compound DZ-2640, in comparison with that of R-95867, faropenem and oral cephalosporins.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactams; Carbapenems; Cephalosporins; Lactams; Microbial Sensitivity Tests | 2000 |
Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Disease Susceptibility; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Humans; Intensive Care Units; Monobactams; Prevalence; Pseudomonas aeruginosa; Staphylococcus aureus | 2001 |
Urinary tract infection in neurogenic bladder.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections | 2001 |
Comparative in vitro antimicrobial activity of a new carbapenem, E1010, and tentative disc diffusion test interpretative criteria.
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Diffusion; Enterobacteriaceae; Imipenem; Meropenem; Microbial Sensitivity Tests; Pyrrolidines; Thienamycins | 2001 |
beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium.
Topics: Animals; Aztreonam; beta-Lactams; Carbapenems; Cephalosporins; Culture Media; Dogs; Humans; Microbial Sensitivity Tests; Penicillins; Plesiomonas | 2001 |
Long-Term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage.
Topics: Carbapenems; Cefotaxime; Cephalosporins; Citrobacter; Combined Modality Therapy; Drainage; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Meningitis, Bacterial; Prognosis; Treatment Outcome | 2001 |
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins | 2001 |
In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
Topics: Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cephalosporins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2002 |
Asymmetric hetero Diels-Alder as an access to carbacephams.
Topics: Carbapenems; Catalysis; Cephalosporins; Chromatography, Thin Layer; Crystallography, X-Ray; Cyclization; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Stereoisomerism; Structure-Activity Relationship | 2002 |
Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.
Topics: Asparagine; beta-Lactamases; Binding Sites; Carbapenems; Cephalosporins; Computational Biology; Isoleucine; Kinetics; Metals; Models, Molecular; Mutagenesis, Site-Directed; Penicillins; Phenylalanine; Protein Binding; Serine; Stenotrophomonas maltophilia; Tyrosine | 2002 |
Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Belgium; Carbapenems; Cephalosporins; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Enterococcus; Follow-Up Studies; Gram-Negative Bacteria; Hematopoietic Stem Cell Transplantation; Humans; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcus; Streptococcus; Transplantation, Autologous; Transplantation, Homologous | 2002 |
Overproduction and biochemical characterization of the Chryseobacterium meningosepticum BlaB metallo-beta-lactamase.
Topics: Bacteria; Binding Sites; Carbapenems; Cephalosporins; Culture Media; DNA, Recombinant; Escherichia coli; Fermentation; Genetic Vectors; Kinetics; Penicillins; Plasmids | 2002 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--I. Gram-positive bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Penicillins; Time Factors | 2002 |
[Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Time Factors | 2002 |
Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.
Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Culture Media; Electrophoresis, Polyacrylamide Gel; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Porins | 2002 |
Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000).
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Enterobacter; Klebsiella; Microbial Sensitivity Tests | 2003 |
[beta-Lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Endocarditis, Bacterial; Humans; Molecular Structure; Monobactams; Neutropenia; Penicillins; Respiratory Tract Infections; Soft Tissue Infections; Staphylococcal Skin Infections; Urinary Tract Infections | 2003 |
Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Colony Count, Microbial; Computer Simulation; Endotoxins; Female; Lipopolysaccharides; Microscopy, Phase-Contrast; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley | 2003 |
Roundtable discussion of antibiotic therapy in surgical infections.
Topics: 4-Quinolones; Abdominal Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drainage; Drug Costs; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Humans; Managed Care Programs; Microbiological Techniques; Minimally Invasive Surgical Procedures; Prescription Fees; Severity of Illness Index; Surgical Wound Infection; Tomography, X-Ray Computed | 2000 |
Amino acid sequence requirements at residues 69 and 238 for the SME-1 beta-lactamase to confer resistance to beta-lactam antibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Cloning, Molecular; Codon; Disulfides; Escherichia coli; Gene Library; Hydrolysis; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Penicillins; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
[Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cephalosporins; Child; Dosage Forms; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Thienamycins; Time Factors | 2002 |
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
Topics: Carbapenems; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Thienamycins; Tuberculosis, Pulmonary | 2003 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Penicillins; Product Surveillance, Postmarketing; Time Factors | 2003 |
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Monobactams; Penicillins; Product Surveillance, Postmarketing; Time Factors | 2003 |
In vitro antimicrobial activity of doripenem, a new carbapenem.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Cephalosporins; Doripenem; Drug Therapy, Combination; Enterobacteriaceae; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam | 2004 |
Pharmacist involvement in antimicrobial use at rural community hospitals in four Western states.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Community Pharmacy Services; Drug Monitoring; Drug Utilization; Health Workforce; Hospitals, Community; Hospitals, Rural; Humans; Idaho; Nevada; Pharmacists; Program Evaluation; Rural Health; Surveys and Questionnaires; Time Factors; Utah; Washington | 2004 |
Retrospective study of clinical outcomes with extended-spectrum beta-lactamases--a different interpretation.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Humans; Retrospective Studies; Time Factors; Treatment Outcome | 2004 |
Impact of positive legionella urinary antigen test on patient management and improvement of antibiotic use.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Bacterial; beta-Lactams; Carbapenems; Cephalosporins; Child, Preschool; Female; Humans; Immunoenzyme Techniques; Legionnaires' Disease; Macrolides; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 2004 |
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome | 2005 |
Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Austria; Carbapenems; Cephalosporins; Chloramphenicol; Francisella tularensis; Hares; Humans; Microbial Sensitivity Tests; Quinolones; Rifampin; Tetracycline; Tularemia | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Brazil; Carbapenems; Cephalosporins; Cohort Studies; Costs and Cost Analysis; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2006 |
[In vitro activity of antimicrobial agents against clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2005 |
[The rate of isolation of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and resistance to antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Bronchi; Carbapenems; Cephalosporins; Ciprofloxacin; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin | 2006 |
In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Enterobacter aerogenes; Humans; Microbial Sensitivity Tests; Molecular Sequence Data | 2006 |
Antibiotic allergy.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Penicillins | 2006 |
Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
Topics: Amikacin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Taiwan | 2006 |
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.
Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection | 2006 |
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Child; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Nepal; Paratyphoid Fever; Salmonella Infections; Salmonella paratyphi A; Salmonella typhimurium; Sentinel Surveillance | 2006 |
In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam | 2006 |
Interscience conference on antimicrobial agents and chemotherapy--46th annual meeting. Release of data for Dc-159a, and other agents. 27-30 September 2006, San Francisco, CA, USA.
Topics: Animals; Anti-Infective Agents; Carbapenems; Cephalosporins; Drugs, Investigational; Estrogen Receptor Modulators; Fluoroquinolones; Humans; Naphthols; Societies, Scientific; United States | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
[Relationship between protein binding and antimicrobial activities of antibiotics against Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Administration, Oral; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Haemophilus influenzae; Humans; Injections, Intravenous; Meropenem; Microbial Sensitivity Tests; Protein Binding; Streptococcus pneumoniae; Thienamycins | 2006 |
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors | 2007 |
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2008 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India.
Topics: Carbapenems; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Intensive Care Units; Microbial Sensitivity Tests | 2007 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
Topics: Aged; Anti-Bacterial Agents; Biopsy, Needle; Blood; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostate; Prostatitis; Ultrasound, High-Intensity Focused, Transrectal; Urinary Tract Infections; Urine | 2008 |
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins | 2008 |
Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Imipenem; Porins | 2008 |
A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, Public; Humans; Infant; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Thailand; Treatment Outcome | 2008 |
Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefepime; Cefuroxime; Cell Line; Cells, Cultured; Cephalosporins; Cloxacillin; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Phagocytosis; Staphylococcus aureus; Thienamycins | 2008 |
[Childhood bacterial meningitis trends in Japan from 2005 to 2006].
Topics: Adolescent; Age Distribution; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Escherichia coli; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Meningitis, Bacterial; Streptococcus pneumoniae; Time Factors | 2008 |
Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.
Topics: Acetylglucosamine; Anti-Bacterial Agents; Binding Sites; Biomimetic Materials; Carbapenems; Ceftaroline; Cell Wall; Cephalosporins; Circular Dichroism; Kinetics; Methicillin Resistance; Muramic Acids; Penicillin-Binding Proteins; Peptide Synthases; Peptidoglycan; Protein Conformation; Staphylococcus aureus | 2008 |
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia | 2008 |
Group Milleri Streptococci in paediatric infections.
Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Child, Preschool; Clindamycin; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Penicillins; Retrospective Studies; Streptococcal Infections; Streptococcus milleri Group; Treatment Outcome | 2009 |
Historical perspectives in critical care medicine: blood transfusion, intravenous fluids, inotropes/vasopressors, and antibiotics.
Topics: ABO Blood-Group System; Animals; Anti-Bacterial Agents; Blood Transfusion; Carbapenems; Cardiotonic Agents; Cephalosporins; Critical Care; Europe; Fluid Therapy; Fluoroquinolones; Glycopeptides; History, 16th Century; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, Ancient; Humans; Infusions, Intravenous; Isotonic Solutions; Japan; Lipopeptides; Military Medicine; Oxazolidinones; Ringer's Solution; United States; Vasoconstrictor Agents | 2009 |
Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Humans; Integrons; Italy; Male; Meropenem; Plasmids; Proteus Infections; Proteus mirabilis; Surgical Wound Infection; Thienamycins; Treatment Failure; Treatment Outcome | 2010 |
Class 1 integron containing metallo beta-lactamase gene blaIMP-1 in carbapenem-resistant Pseudomonas aeruginosa in Thailand.
Topics: Amino Acid Sequence; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Integrons; Molecular Epidemiology; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Thailand | 2009 |
Arabidopsis thaliana mitochondrial glyoxalase 2-1 exhibits beta-lactamase activity.
Topics: Amino Acid Sequence; Arabidopsis; Arabidopsis Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Humans; Hydrolysis; Isoenzymes; Mitochondria; Mitochondrial Proteins; Molecular Sequence Data; Protein Folding; Substrate Specificity; Thiolester Hydrolases | 2009 |
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Doxycycline; Drug Utilization; Health Services Research; Hospitals; Humans; Infection Control; Organizational Policy; Prevalence; Quinolones | 2010 |
Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Efficacy of treatment with carbapenems and third-generation cephalosporins for patients with febrile complicated pyelonephritis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Female; Fever; Humans; Male; Middle Aged; Pyelonephritis; Urine | 2009 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan | 2010 |
Use of ChromID extended-spectrum beta-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Colony Count, Microbial; Culture Media; Enterobacteriaceae; Microbial Sensitivity Tests | 2010 |
Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Cyclotrons; Doripenem; Ertapenem; Fourier Analysis; Hydrogen Bonding; Indicators and Reagents; Kinetics; Mass Spectrometry; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Protein Conformation | 2010 |
Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Haemophilus influenzae; Health Care Surveys; Humans; Infant; Japan; Male; Meningitis, Bacterial; Meningitis, Haemophilus; Meningitis, Pneumococcal; Middle Aged; Prognosis; Streptococcus pneumoniae; Treatment Outcome; Young Adult | 2010 |
Complete nucleotide sequence of Klebsiella pneumoniae multidrug resistance plasmid pKP048, carrying blaKPC-2, blaDHA-1, qnrB4, and armA.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Klebsiella pneumoniae; Models, Genetic; Molecular Sequence Data; Plasmids | 2010 |
Elucidating the role of Trp105 in the KPC-2 β-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Escherichia coli; Gene Expression; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Penicillins; Tryptophan | 2010 |
Genotypic analysis of plasmid-mediated beta-lactamases amongst Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. that are non-susceptible to a broad-spectrum cephalosporin.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Enterobacteriaceae; Escherichia; Humans; Klebsiella; Microbial Sensitivity Tests; Plasmids | 2010 |
Ferrier-Petasis rearrangement of 4-(vinyloxy)azetidin-2-ones: an entry to carbapenams and carbacephams.
Topics: Azetidines; Carbapenems; Cephalosporins; Molecular Conformation; Stereoisomerism | 2010 |
IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Male; Middle Aged; Monobactams; Penicillins; Skin Tests; Young Adult | 2010 |
Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan.
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Guideline Adherence; Laboratories; Microbial Sensitivity Tests; Taiwan | 2010 |
Activity of ACHN-490 tested alone and in combination with other agents against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa | 2011 |
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Imipenem; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2011 |
[Interpretation of the susceptibility test results in enterobacteria producing 3rd- and 4th-generation cephalosporin- or carbapenem-hydrolyzing beta-lactamases].
Topics: beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests | 2011 |
Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2011 |
Melioidosis, phnom penh, Cambodia.
Topics: Adolescent; Adult; Aged; Burkholderia pseudomallei; Cambodia; Carbapenems; Cephalosporins; Diabetes Mellitus, Type 2; Diagnostic Errors; Doxycycline; Female; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Sulfamethoxazole; Survival Rate; Trimethoprim | 2011 |
Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Research Design | 2012 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; United Kingdom | 2011 |
Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals.
Topics: Accounting; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Therapy; Drug Utilization; Drug Utilization Review; Hospitals; Humans; Patients' Rooms; Pharmaceutical Services; Quinolones; Reproducibility of Results | 2011 |
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome | 2012 |
Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Cloning, Molecular; Enterobacteriaceae Infections; Escherichia coli; Humans; Hydrolysis; Kinetics; Male; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Peritonitis; Postoperative Complications; Protein Structure, Tertiary | 2012 |
NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Humans; Hydrolysis; Kinetics; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Urinary Tract Infections | 2012 |
Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya.
Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Gram-Negative Bacterial Infections; Humans; Integrons; Kinetics; Libya; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Alignment; Sequence Homology, Amino Acid | 2012 |
Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Chryseobacterium; DNA Primers; DNA, Recombinant; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Immunoprecipitation; Real-Time Polymerase Chain Reaction; RNA, Bacterial | 2012 |
[Frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, Caracas, Venezuela].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Phenotype; Substrate Specificity; Venezuela | 2011 |
Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; Infant; Integrases; Malaysia; Microbial Sensitivity Tests; Phylogeny; Prevalence; Tertiary Care Centers | 2012 |
Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Female; Humans; Immunosuppressive Agents; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Rate; Young Adult | 2012 |
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic | 2012 |
OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Egypt; Female; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Sequence Data; Sequence Analysis, DNA | 2012 |
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Inactivation of Mycobacterium tuberculosis l,d-transpeptidase LdtMt₁ by carbapenems and cephalosporins.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clavulanic Acid; Extensively Drug-Resistant Tuberculosis; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Thienamycins | 2012 |
Carbapenem antibiotics for serious infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Cephalosporins; Cost-Benefit Analysis; Humans | 2012 |
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies | 2012 |
Chromatographic separation studies of penicillins, cephalosporins and carbapenems on transition-metal silicate modified silica layers.
Topics: Carbapenems; Cephalosporins; Chromatography, Thin Layer; Penicillins; Silicates; Silicon Dioxide; Transition Elements | 2012 |
Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6.
Topics: Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Carbapenems; Cephalosporins; Escherichia coli; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Penicillins; Substrate Specificity | 2012 |
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.
Topics: Acinetobacter baumannii; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Isoenzymes; Kinetics; Models, Molecular; Mutation; Recombinant Proteins; Structure-Activity Relationship | 2012 |
Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome | 2013 |
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests | 2013 |
[Antibacterial therapy in acute nonbiliary infectious necrotizing pancreatitis].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drainage; Female; Fluoroquinolones; Humans; Inflammation; Male; Middle Aged; Pancreas; Pancreatitis, Acute Necrotizing; Survival Rate | 2012 |
[Morphological changes in penicillin-resistant Streptococcus pneumoniae and beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae after exposure to oral antibacterial agents].
Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteriolysis; beta-Lactamases; Carbapenems; Cephalosporins; Child; Dose-Response Relationship, Drug; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Microscopy, Phase-Contrast; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Time Factors | 2012 |
Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care Facilities; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Confidence Intervals; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Nursing Homes; Odds Ratio; Retrospective Studies; Sex Factors; United States; Young Adult | 2013 |
Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Sequence Analysis, DNA | 2013 |
Comprehensive analysis of ß-lactam antibiotics including penicillins, cephalosporins, and carbapenems in poultry muscle using liquid chromatography coupled to tandem mass spectrometry.
Topics: Animals; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Chromatography, Liquid; Limit of Detection; Muscle, Skeletal; Penicillins; Poultry; Tandem Mass Spectrometry | 2013 |
OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chromosomes, Bacterial; Cloning, Molecular; DNA Transposable Elements; Escherichia coli; Humans; Isoenzymes; Molecular Sequence Data; Mutation; Plasmids; Recombinant Proteins; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2013 |
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Retrospective Studies; Risk Factors | 2013 |
Looking for the new preparations for antibacterial therapy. II. Clinical trials; new beta-lactam antibiotics and beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Drugs, Investigational; Female; Humans; Male; Monobactams; Pregnancy | 2013 |
Reply to Altshuler et al.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Treatment of extended-spectrum Beta-lactamase enterobacteriaceae with cefepime: the dose matters, too.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
When pharmacodynamics trump costs: an antimicrobial stewardship program's approach to selecting optimal antimicrobial agents.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Doripenem; Drug Costs; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2013 |
Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.
Topics: Acinetobacter; Amino Acid Sequence; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Crystallography, X-Ray; Doripenem; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2013 |
Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Feces; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Young Adult | 2013 |
In vitro antibacterial activities of two novel oral antibiotics, tebipenem and cefditoren, and other comparators against community-acquired respiratory tract infection-associated bacterial pathogens: a multicentre study in China.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; China; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 2014 |
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult | 2013 |
[Analysis of the carbapenemase-producing mechanism of Enterobacteriaceae with decreased susceptibility to carbapenems].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Enterobacteriaceae; Ertapenem; Gene Amplification; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2013 |
Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Infection Control | 2013 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Porins; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA | 2014 |
Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals; Humans; Integrons; Iran; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2014 |
Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; China; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Hospitals; Humans; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Survival Analysis | 2014 |
Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Escherichia coli; Molecular Docking Simulation; Molecular Dynamics Simulation; Penicillin-Binding Proteins; Peptide Synthases; Protein Binding; Staphylococcus aureus; Streptococcus pneumoniae | 2014 |
Severe cutaneous adverse reactions related to systemic antibiotics.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Eruptions; Eosinophilia; Female; Glycopeptides; Humans; Male; Middle Aged; Penicillins; Quinolones; Retrospective Studies; Stevens-Johnson Syndrome; Taiwan | 2014 |
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2014 |
pRMH760, a precursor of A/C₂ plasmids carrying blaCMY and blaNDM genes.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Gene Expression Regulation, Bacterial; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Phenotype; Plasmids | 2014 |
Dissemination in Japan of multidrug-resistant Pseudomonas aeruginosa isolates producing IMP-type metallo-β-lactamases and AAC(6')-Iae/AAC(6')-Ib.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Inosine Monophosphate; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Detection of carbapenem resistance genes and cephalosporin, and quinolone resistance genes along with oqxAB gene in Escherichia coli in hospital wastewater: a matter of concern.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Molecular Sequence Data; Phylogeny; Quinolones; Wastewater | 2014 |
Molecular mechanisms of substrate recognition and specificity of New Delhi metallo-β-lactamase.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Cephalosporins; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Substrate Specificity | 2014 |
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Drug Resistance; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 2014 |
Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
Twelve-year survey (2001-2012) of the antimicrobial susceptibility of Streptococcus pneumoniae isolates from otorhinolaryngology clinics in Miyagi Prefecture, Japan.
Topics: Adolescent; Adult; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Ear; Fluoroquinolones; Humans; Infant; Infant, Newborn; Japan; Lincosamides; Macrolides; Microbial Sensitivity Tests; Middle Aged; Mouth; Nose; Otolaryngology; Penicillins; Pharynx; Streptococcus pneumoniae; Young Adult | 2014 |
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2015 |
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation | 2014 |
Molecular characterization of carbapenemase and cephalosporinase genes among clinical isolates of Acinetobacter baumannii in a tertiary medical centre in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Child; Child, Preschool; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Ribosomal; Female; Humans; Infant; Infant, Newborn; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tertiary Care Centers; Young Adult | 2015 |
Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lebanon; Microbial Sensitivity Tests; Organ Specificity; Substrate Specificity | 2014 |
Click N-benzyl iminodiacetic acid: novel silica-based tridentate zwitterionic stationary phase for hydrophilic interaction liquid chromatography.
Topics: Alkynes; Azides; Benzoates; Carbapenems; Cephalosporins; Chromatography, Liquid; Click Chemistry; Cycloaddition Reaction; Hydrophobic and Hydrophilic Interactions; Imino Acids; Purines; Pyrimidines; Silica Gel; Solutions; Sulfadiazine | 2015 |
Biochemical characterization of the POM-1 metallo-β-lactamase from Pseudomonas otitidis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Escherichia coli; Penicillins; Pseudomonas | 2015 |
Structural and biochemical characterization of VIM-26 shows that Leu224 has implications for the substrate specificity of VIM metallo-β-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Binding Sites; Carbapenems; Catalysis; Cephalosporins; Crystallography, X-Ray; Drug Resistance, Bacterial; Ions; Klebsiella pneumoniae; Leucine; Penicillins; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins; Serine; Substrate Specificity | 2015 |
Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Surveys and Questionnaires; Taiwan | 2016 |
Impact of Clostridium difficile recurrence on hospital readmissions.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fluoroquinolones; Humans; Intensive Care Units; Linezolid; Multivariate Analysis; Patient Readmission; Recurrence; Regression Analysis; Retrospective Studies; Vancomycin | 2015 |
Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged | 2015 |
Profiling of β-lactam selectivity for penicillin-binding proteins in Streptococcus pneumoniae D39.
Topics: Amdinocillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Doripenem; Electrophoresis, Polyacrylamide Gel; Meropenem; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins | 2015 |
Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens | 2015 |
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Ceftazidime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Iodides; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Protein Conformation | 2015 |
Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Carbapenems; Carrier Proteins; Cephalosporins; Drug Resistance, Multiple, Bacterial; Genetic Variation; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Serine-Type D-Ala-D-Ala Carboxypeptidase | 2015 |
ERCP scopes: what can we do to prevent infections?
Topics: Carbapenems; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male | 2015 |
Silica-based 2-(N,N-dimethylamino)-1,3-propanediol hydrophilic interaction liquid chromatography stationary phase for separating cephalosporins and carbapenems.
Topics: Alkynes; Azides; Carbapenems; Cephalosporins; Chromatography, High Pressure Liquid; Cycloaddition Reaction; Propylene Glycols; Silicon Dioxide | 2015 |
Characterization of BKC-1 class A carbapenemase from Klebsiella pneumoniae clinical isolates in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Penicillins; Sinorhizobium meliloti | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Consecutive radical S-adenosylmethionine methylations form the ethyl side chain in thienamycin biosynthesis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catalysis; Cephalosporins; Chromatography, Liquid; Cloning, Molecular; DNA Methylation; Drug Design; Escherichia coli; Fermentation; Methylation; Penicillins; S-Adenosylmethionine; Streptomyces; Tandem Mass Spectrometry; Thienamycins; Vitamin B 12 | 2015 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Molecular Docking Simulation | 2015 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Enterobacteriaceae; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Siderophores | 2016 |
Biochemical Characterization of CPS-1, a Subclass B3 Metallo-β-Lactamase from a Chryseobacterium piscium Soil Isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Penicillins; Sequence Alignment; Soil Microbiology | 2015 |
Should we fear tubing adsorption of antibacterial drugs in extracorporeal membrane oxygenation? An answer for cephalosporins and carbapenems.
Topics: Adsorption; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Extracorporeal Membrane Oxygenation; Humans | 2016 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine,
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Doripenem; Feces; Fluoroquinolones; Heterocyclic Compounds, 3-Ring; Humans; Imipenem; Linezolid; Naphthyridines; Oxazines; Oxolinic Acid; Pefloxacin; Piperazines; Pyridones; Retrospective Studies; Rifampin | 2016 |
Crystal Structures of KPC-2 and SHV-1 β-Lactamases in Complex with the Boronic Acid Transition State Analog S02030.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Carbapenems; Catalytic Domain; Cephalosporins; Crystallography, X-Ray; Klebsiella pneumoniae; Protein Structure, Tertiary; Thiophenes; Triazoles | 2016 |
Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; DNA Mismatch Repair; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Mutation Rate; Penicillin-Binding Proteins; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2016 |
Characterization of VCC-1, a Novel Ambler Class A Carbapenemase from Vibrio cholerae Isolated from Imported Retail Shrimp Sold in Canada.
Topics: Amino Acid Sequence; Animals; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Canada; Carbapenems; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Penaeidae; Penicillanic Acid; Penicillins; Seafood; Sequence Alignment; Sequence Analysis, DNA; Tazobactam; Vibrio cholerae | 2016 |
Who should receive extended infusion beta-lactam therapy?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Patient Selection; Penicillins | 2016 |
Distribution and Relationships of Antimicrobial Resistance Determinants among Extended-Spectrum-Cephalosporin-Resistant or Carbapenem-Resistant Escherichia coli Isolates from Rivers and Sewage Treatment Plants in India.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; India; Microbial Sensitivity Tests; Plasmids; Rivers; Sewage; Water Purification | 2016 |
[OFF-LABEL DRUG USAGE IN THE TREATMENT OF URINARY TRACT INFECTION OF NEWBORNS].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Hypersensitivity; Drug Labeling; Dysbiosis; Female; Humans; Infant; Infant, Newborn; Length of Stay; Macrolides; Male; Moscow; Off-Label Use; Sulfonamides; Urinary Tract Infections | 2015 |
Impact of Cefepime Susceptible-Dose-Dependent MIC for Enterobacteriaceae on Reporting and Prescribing.
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Prescriptions; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2016 |
Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Hydrolysis; Mutation; Penicillins; Plasmids; Protein Conformation; Substrate Specificity; Turkey | 2016 |
Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Pneumonia, Ventilator-Associated; Pulmonary Surfactants; Risk Factors; Treatment Outcome | 2016 |
Impact of computerized pre-authorization of broad spectrum antibiotics in Pseudomonas aeruginosa at a children's hospital in Japan.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tokyo | 2016 |
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Expression; Gene Transfer, Horizontal; Greece; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Quinolones; Replicon; Survival Analysis | 2016 |
Crystal Structure of the Metallo-β-Lactamase GOB in the Periplasmic Dizinc Form Reveals an Unusual Metal Site.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Cations, Divalent; Cephalosporins; Cloning, Molecular; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Flavobacteriaceae; Gene Expression; Glutamine; Histidine; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Penicillins; Periplasm; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Domains; Protein Structure, Tertiary; Recombinant Proteins; Substrate Specificity; Zinc | 2016 |
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Belgium; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Gene Expression; Germany; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; United Kingdom | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; France; Gene Expression; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Hospitals; Humans; Microbial Sensitivity Tests; Monobactams; Mutation; Penicillins; Phylogeny; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Spain | 2016 |
Pyogenic Liver Abscess: A Retrospective Study of 105 Cases in an Emergency Department from East China.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Carbapenems; Cephalosporins; Chills; China; Emergency Service, Hospital; Fatigue; Female; Fever; Humans; Klebsiella pneumoniae; Leukocytosis; Liver Abscess, Pyogenic; Male; Metronidazole; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Utilization; Fluoroquinolones; Hand Hygiene; Hospitals; Humans; Infection Control; Middle Aged; Prevalence; Scotland | 2017 |
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline | 2017 |
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, Teaching; Humans; Isoenzymes; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Plasmids; Sequence Analysis, DNA | 2017 |
OXA-48-producing ST372 Escherichia coli in a French dog.
Topics: Animals; beta-Lactamases; Carbapenems; Cats; Cephalosporins; Dogs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins | 2017 |
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections | 2017 |
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin | 2017 |
Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring System
Topics: Anti-Bacterial Agents; Asian People; Carbapenems; Cephalosporins; Databases, Factual; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Republic of Korea; Secondary Care Centers; Tertiary Care Centers | 2017 |
Broad-spectrum antibiotics in Norwegian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization Review; Guideline Adherence; Hospitals; Humans; Norway; Piperacillin; Quinolones; Respiratory Tract Infections | 2017 |
Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Propensity Score; Treatment Outcome | 2017 |
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Female; Humans; Male; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam | 2017 |
Clinical features and antimicrobial resistance profiles of important Enterobacteriaceae pathogens in Guangzhou representative of Southern China, 2001-2015.
Topics: Amikacin; Anti-Bacterial Agents; Blood; Carbapenems; Ceftazidime; Cephalosporins; China; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sputum; Urinary Tract | 2017 |
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inpatients; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Thienamycins; Tigecycline | 2017 |
IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Gene Transfer, Horizontal; Humans; Imipenem; Klebsiella; Meropenem; Plasmids; Thienamycins; United Kingdom | 2017 |
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospital Mortality; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2017 |
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline | 2017 |
Drug allergy evaluation for betalactam hypersensitivity: Cross-reactivity with cephalosporines, carbapenems and negative predictive value.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Child; Cross Reactions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Predictive Value of Tests; Skin Tests | 2018 |
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Cross-Over Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Monobactams; Pneumonia; Pneumonia, Ventilator-Associated; Prospective Studies; Quinolones; Respiration, Artificial; Statistics, Nonparametric | 2017 |
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2017 |
In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Mutation; Nitrobenzenes; Penicillins; Porins; Tetracyclines; Urinary Tract Infections | 2017 |
Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.
Topics: Anti-Bacterial Agents; Carbapenems; Cell Wall; Cephalosporins; Crystallography, X-Ray; Drug Synergism; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Penicillins; Peptidoglycan; Peptidyl Transferases; Protein Structure, Tertiary | 2017 |
A novel transposon, Tn6306, mediates the spread of bla
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; China; DNA Transposable Elements; DNA, Bacterial; Enterobacteriaceae Infections; Hospitals; Humans; Incidence; Microbial Sensitivity Tests; Plasmids; Retrospective Studies; Sequence Analysis, DNA | 2017 |
Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections | 2018 |
Modified Penicillin Molecule with Carbapenem-Like Stereochemistry Specifically Inhibits Class C β-Lactamases.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Catalytic Domain; Cephalosporins; Clavulanic Acid; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Penicillins; Stereoisomerism; Sulbenicillin | 2017 |
The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Intensive Care Units; Klebsiella Infections; Longitudinal Studies; Microbial Sensitivity Tests; Models, Theoretical; Prospective Studies | 2018 |
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
Topics: Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Cohort Studies; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Rectum | 2017 |
Peptidoglycan Cross-Linking Activity of l,d-Transpeptidases from Clostridium difficile and Inactivation of These Enzymes by β-Lactams.
Topics: Acylation; Ampicillin; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Hydrolysis; Mass Spectrometry; Peptidoglycan; Peptidyl Transferases | 2018 |
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome | 2018 |
The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Crystallization; Crystallography, X-Ray; Escherichia coli; Hydrolysis; Imipenem; Magnetic Resonance Spectroscopy; Meropenem; Models, Molecular; Penicillins; Thienamycins | 2017 |
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests | 2018 |
Laboratory surveillance of antimicrobial resistance and multidrug resistance among Streptococcus pneumoniae isolated in the Kinki region of Japan, 2001-2015.
Topics: Adult; Carbapenems; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Japan; Macrolides; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae | 2018 |
Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; France; Glycopeptides; Guidelines as Topic; Hospitals; Humans; Intensive Care Units; Logistic Models; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Prescriptions; Probability; Retrospective Studies | 2018 |
Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Developed Countries; Developing Countries; Drug Resistance, Multiple, Bacterial; Escherichia coli; Forecasting; Humans; Klebsiella pneumoniae; Linear Models; Microbial Sensitivity Tests | 2018 |
Microbial Spectrum of Intra-Abdominal Abscesses in Perforating Crohn's Disease: Results from a Prospective German Registry.
Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; beta-Lactamase Inhibitors; Candida albicans; Carbapenems; Cephalosporins; Crohn Disease; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterococcus; Female; Germany; Humans; Immunosuppressive Agents; Intestinal Perforation; Length of Stay; Levofloxacin; Male; Penicillins; Prospective Studies; Quinolones; Registries; Streptococcus; Young Adult | 2018 |
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers | 2018 |
Detection of qnrVC6, within a new genetic context, in an NDM-1-producing Citrobacter freundii clinical isolate from Uruguay.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Plasmids; Quinolones; Uruguay | 2018 |
Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Logistic Models; Male; Microbial Sensitivity Tests; Prevalence; Regression Analysis; United States | 2019 |
Which non-carbapenem antibiotics are active against extended-spectrum β-lactamase-producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam; Urinary Tract Infections | 2018 |
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; United States | 2018 |
Maintenance of Carbapenemase-Producing Enterobacteriaceae in a Farrow-to-Finish Swine Production System.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Farms; Feces; Female; Livestock; Male; Plasmids; Pregnancy; Swine; Swine Diseases | 2018 |
ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Child; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; South Africa | 2018 |
Sequencing of pT5282-CTXM, p13190-KPC and p30860-NR, and comparative genomics analysis of IncX8 plasmids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Evolution, Molecular; Fluoroquinolones; Gene Expression; Genetic Variation; Genomics; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multigene Family; Penicillins; Phylogeny; Plasmids; Replicon | 2018 |
Enterobacter cloacae Complex Isolated from Shrimps from Vietnam Carrying
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacter cloacae; Fisheries; Interspersed Repetitive Sequences; Microbial Sensitivity Tests; Penaeidae; Shellfish; Vietnam | 2018 |
First report of the isolation of bla
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Japan; Levofloxacin; Microbial Sensitivity Tests | 2018 |
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult | 2018 |
An ancient family of mobile genomic islands introducing cephalosporinase and carbapenemase genes in Enterobacteriaceae.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genome, Bacterial; Genomic Islands; Humans; Infant, Newborn; Klebsiella pneumoniae; Mass Spectrometry; Microbial Sensitivity Tests; Prophages; Sequence Analysis, DNA | 2018 |
Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Global Health; Humans; Klebsiella pneumoniae; Models, Statistical; World Health Organization | 2018 |
No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Female; Genes, Bacterial; Humans; Klebsiella pneumoniae; Male; Mutation; Phylogeny; Virulence; Virulence Factors | 2018 |
Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Chromosomes, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2018 |
Identification and Characterization of IncA/C Conjugative,
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Microbial Sensitivity Tests; Penaeidae; Plasmids; Seafood; Sequence Analysis, DNA; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio alginolyticus | 2018 |
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors | 2018 |
Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae.
Topics: beta-Lactam Resistance; beta-Lactamases; Bile; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Citrobacter freundii; Conjugation, Genetic; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Plasmids; Rectum; Whole Genome Sequencing | 2019 |
Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Klebsiella pneumoniae; Physicians; Pseudomonas aeruginosa; Republic of Korea; Specialization; Staphylococcus aureus | 2018 |
Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Gene Expression; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2019 |
The structures of penicillin-binding protein 4 (PBP4) and PBP5 from
Topics: Acylation; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Catalytic Domain; Cephalosporins; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Penicillins; Protein Conformation; Protein Domains; Protein Isoforms | 2018 |
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics.
Topics: Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cephalosporins; Codon; Drug Resistance, Bacterial; Escherichia coli; High-Throughput Nucleotide Sequencing; Imipenem; Mutation; Penicillins | 2018 |
Rapid detection of resistance to carbapenems and cephalosporins in Enterobacteriaceae using liquid chromatography tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Chromatography, High Pressure Liquid; Enterobacteriaceae Infections; Escherichia coli; Humans; Hydrolysis; Microbial Sensitivity Tests; Tandem Mass Spectrometry; Time Factors | 2018 |
Rapid detection of beta-lactamase production including carbapenemase by thin layer chromatography.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporin Resistance; Cephalosporins; Chromatography, Thin Layer; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Penicillins; Prevalence; Pseudomonas aeruginosa; Quinolones; Retrospective Studies; Tertiary Care Centers | 2018 |
Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Humans; Microbial Sensitivity Tests; Netherlands; Prevalence; Registries; Streptococcal Infections; Streptococcus mitis; Streptococcus oralis | 2019 |
Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Fluoroquinolones; France; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Practice Patterns, Physicians'; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Standard of Care | 2019 |
Novel Antibiotics in the Treatment of Urinary Tract Infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections | 2019 |
Identification of
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genes, Bacterial; Hospitals; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Microbial Sensitivity Tests; Penicillins; Tetracyclines; Whole Genome Sequencing | 2019 |
Exposure to Sublethal Concentrations of Benzalkonium Chloride Induces Antimicrobial Resistance and Cellular Changes in
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Local; Benzalkonium Compounds; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Fluoroquinolones; Gene Expression; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Nitrobenzenes; Penicillins; Tetracyclines | 2019 |
Hidden Carbapenem Resistance in OXA-48 and Extended-Spectrum β-Lactamase-Positive
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Conjugation, Genetic; Croatia; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2019 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Boronic Acids; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous | 2019 |
Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae Infections; Humans; Hydrolysis; Microbial Sensitivity Tests; Reproducibility of Results | 2019 |
Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles.
Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carbapenems; Cephalosporin Resistance; Cephalosporins; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae | 2019 |
Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Cohort Studies; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2019 |
Influence of antibiotic pressure on multi-drug resistant
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies | 2019 |
Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nephritis; Retrospective Studies; Spain | 2019 |
A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015-2016.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Europe, Eastern; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Lebanon; Microbial Sensitivity Tests; Population Surveillance; Retrospective Studies | 2019 |
Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Scotland; Tazobactam; Whole Genome Sequencing | 2019 |
A Combination Antibiogram Evaluation for
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States | 2019 |
Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Naphthyridines; Otitis Media; Pneumococcal Vaccines; Quinolones; Streptococcus pneumoniae; Vaccines, Conjugate | 2019 |
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; United States | 2019 |
Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA
Topics: beta-Lactam Resistance; California; Carbapenems; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Geography, Medical; Humans; Microbial Sensitivity Tests | 2019 |
Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Epidemiological Monitoring; Female; Humans; Infant; Intensive Care Units, Neonatal; Male; Pediatrics; Prospective Studies; Saudi Arabia; Vancomycin | 2019 |
Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Culture Media; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Mutation; Plasmids; Recombinant Proteins; Surgical Wound Infection; Switzerland; Zinc | 2019 |
Dual Role of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Lepidoptera; Microbial Sensitivity Tests; Minocycline; Tigecycline; Virulence | 2019 |
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Europe; European Union; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sentinel Surveillance | 2019 |
CreC Sensor Kinase Activation Enhances Growth of Escherichia coli in the Presence of Cephalosporins and Carbapenems.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Protein Kinases; Regulon | 2019 |
New Trimodal Phenotypic Reporter of Extended-Spectrum β-Lactamase Activity.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Biosensing Techniques; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxazines; Sulfides | 2019 |
Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; Cohort Studies; Colombia; Cross Infection; Diagnostic Imaging; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Health Expenditures; Hospitalization; Hospitals, Urban; Humans; Male; Middle Aged; Tertiary Care Centers; Urinary Tract Infections | 2019 |
Genomic Insights into Two Colistin-Resistant
Topics: Anti-Bacterial Agents; Base Sequence; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Feces; Fluoroquinolones; Genes, Bacterial; Genomics; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Plasmids; Virulence; Whole Genome Sequencing | 2020 |
Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Pakistan; United States | 2020 |
Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Humans; Siderophores | 2019 |
First Occurrence of the OXA-198 Carbapenemase in
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Citrobacter; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Penicillins; Plasmids | 2020 |
Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Clindamycin; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Retrospective Studies | 2020 |
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Canada; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Siderophores; Stenotrophomonas maltophilia | 2020 |
First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections.
Topics: Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genomics; Humans; India; Polymorphism, Single Nucleotide; Virulence; Whole Genome Sequencing | 2020 |
[ANALYSIS OF THE USE OF ANTIBIOTIC THERAPY IN PREMATURE INFANTS, TAKING INTO ACCOUNT THE CHARACTERISTICS OF THE NEONATAL PERIOD].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Respiratory System | 2020 |
QM/MM investigation of substrate binding of subclass B3 metallo-β-lactamase SMB-1 from Serratia marcescents: insights into catalytic mechanism.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Models, Chemical; Serratia marcescens | 2020 |
Substrate Specificity of OXA-48 after β5-β6 Loop Replacement.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Crystallography, X-Ray; Kinetics; Substrate Specificity | 2020 |
Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Utilization; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillins; Retrospective Studies; Tertiary Care Centers | 2020 |
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Molecular diversity of chromosomal metallo-β-lactamase genes in Elizabethkingia genus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Flavobacteriaceae; Flavobacteriaceae Infections; Genetic Variation; Humans; Microbial Sensitivity Tests; Phylogeny; Sequence Alignment | 2020 |
Metagenomics reveals impact of geography and acute diarrheal disease on the Central Indian human gut microbiome.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Carbapenems; Cephalosporins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Microbiome; Humans; India; Male; Metagenomics; Middle Aged; Rural Population; Urban Population; Young Adult | 2020 |
The Effect of Beta-lactam Allergy Status on the Rate of Surgical Site Infections: A Retrospective Cohort Study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Cefazolin; Cephalosporins; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Risk Factors; Surgical Wound Infection | 2022 |
A highly multiplexed melt-curve assay for detecting the most prevalent carbapenemase, ESBL, and AmpC genes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Sensitivity and Specificity | 2020 |
Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Liver Cirrhosis; Peritonitis; Retrospective Studies | 2021 |
Expansion of acquired 16S rRNA methytransferases along with CTX-M-15, NDM and OXA-48 within three sequence types of Escherichia coli from northeast India.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Humans; India; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2020 |
Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Topics: Anti-Bacterial Agents; Asia; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Europe; Latin America; Microbial Sensitivity Tests; Phylogeny; Tetracyclines; United States | 2020 |
Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies | 2021 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
Cefiderocol: the Trojan horse has arrived but will Troy fall?
Topics: Bacteria; Carbapenems; Cefiderocol; Cephalosporins; Gram-Negative Bacteria | 2021 |
Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Ceftaroline; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Genome, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Staphylococcal Infections | 2020 |
Analysis of antibiotic treatment of children in a Shanghai tertiary hospital based on point prevalence surveys.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Cephalosporins; Child; Child, Preschool; China; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Penicillins; Prescriptions; Prevalence; Surveys and Questionnaires; Tertiary Care Centers | 2020 |
Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cymenes; DNA Gyrase; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Gene Expression; Microbial Sensitivity Tests; Oils, Volatile; Origanum; Polycyclic Sesquiterpenes; Polymyxin B | 2020 |
Amending the Efficiency of Antimicrobials against Multidrug-Resistant Pseudomonas aeruginosa by Low-Frequency Magnetic Fields.
Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Fields; Microbial Sensitivity Tests; Penicillins; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 2020 |
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam | 2020 |
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Fosfomycin; Klebsiella pneumoniae; Piperacillin; Tetracyclines | 2021 |
AmpC- and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Detected in Fresh Produce in Central Ohio.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Food Contamination; Food Microbiology; Ohio; Vegetables | 2021 |
Risk comparison of beta-lactam-induced anaphylaxis: Therapeutic stratification analysis in a Vietnamese pharmacovigilance database.
Topics: Age Factors; Anaphylaxis; Anti-Bacterial Agents; Asian People; beta-Lactams; Carbapenems; Cephalosporins; Drug Therapy, Combination; Humans; Penicillins; Pharmacovigilance; Risk Factors; Sex Factors; Vietnam | 2021 |
The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefuroxime; Cephalosporins; Colorectal Surgery; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Metronidazole; Spectroscopy, Fourier Transform Infrared | 2021 |
Transcriptional expression of secondary resistance genes ccdB and repA2 is enhanced in presence of cephalosporin and carbapenem in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cephalosporins; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests | 2021 |
Prevalence of extended-spectrum cephalosporin-, carbapenem-, and fluoroquinolone-resistant members of the family Enterobacteriaceae isolated from the feces of horses and hospital surfaces at two equine specialty hospitals.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Enterobacteriaceae; Feces; Fluoroquinolones; Horses; Hospitals; Ohio; Prevalence | 2021 |
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Autografts; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Tazobactam; Treatment Outcome; Young Adult | 2021 |
Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens.
Topics: Carbapenems; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Humans | 2021 |
Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Burkholderia cepacia; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Linear Models; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Tetracyclines | 2021 |
Trends in Antipseudomonal Agent Use Based on the 2006 to 2015 Sales Data in Japan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Commerce; Drug Utilization; Fluoroquinolones; Humans; Japan; Penicillins; Pseudomonas Infections | 2021 |
Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Enterobacter cloacae; Humans; Microbial Sensitivity Tests; Mutation; Siderophores | 2022 |
Role of AmpG in the resistance to β-lactam agents, including cephalosporins and carbapenems: candidate for a novel antimicrobial target.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cephalosporins; CRISPR-Cas Systems; Democratic People's Republic of Korea; DNA Transposable Elements; Gene Expression Regulation, Bacterial; Gene Knockout Techniques; Humans; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutagenesis; Sequence Alignment | 2021 |
Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Disk Diffusion Antimicrobial Tests; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae | 2021 |
Phenotypic/Genotypic Profile of OXA-10-Like-Harboring, Carbapenem-Resistant Pseudomonas aeruginosa: Using Validated Pharmacokinetic/Pharmacodynamic
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Humans; Mice; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins | 2021 |
Anatomy of a successful stewardship intervention: Improving perioperative prescribing in penicillin-allergic patients.
Topics: Anti-Bacterial Agents; Carbapenems; Cefazolin; Cefuroxime; Cephalosporins; Drug Hypersensitivity; Humans; Penicillins | 2022 |
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
Carbapenem-Resistant Enterobacterales Infection After Massive Blast Injury: Use of Cefiderocol Based Combination Therapy.
Topics: Anti-Bacterial Agents; Blast Injuries; Carbapenems; Cefiderocol; Cephalosporins; Escherichia coli; Humans; Male; Microbial Sensitivity Tests | 2021 |
Activity of imipenem-relebactam and ceftolozane-tazobactam against carbapenem-resistant Pseudomonas aeruginosa and KPC-producing Enterobacterales.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tazobactam | 2022 |
Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Uptake in newly approved antibiotics prescribed to patients with carbapenem-resistant Enterobacterales (CRE).
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Humans | 2023 |
In vitro activity of cefiderocol against Gram-negative bacterial pathogens in Germany.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Tazobactam | 2022 |
Prevalence of enteric opportunistic pathogens and extended-spectrum cephalosporin- and carbapenem-resistant coliforms and genes in wastewater from municipal wastewater treatment plants in Croatia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Croatia; Escherichia coli; Microbial Sensitivity Tests; Prevalence; Wastewater; Water Purification | 2022 |
[Penicillin allergy].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Penicillins; Skin Tests | 2022 |
Successful prolonged treatment of a carbapenem-resistant Acinetobacter baumannii hip infection with cefiderocol: A case report.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis | 2022 |
Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Piperacillin; Pseudomonas aeruginosa; Tazobactam | 2022 |
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Drug Combinations; Humans; Meropenem; Microbial Sensitivity Tests | 2022 |
Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experience.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam; Tertiary Care Centers | 2022 |
Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Porins | 2022 |
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis | 2022 |
Third-Generation Cephalosporin-Resistant
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins | 2022 |
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines | 2022 |
In a Pinch: Cefiderocol for CRAB Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cephalosporins; Child; Communicable Diseases; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; United States | 2022 |
Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Reproducibility of Results | 2022 |
In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Combinations; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Rifampin; Tazobactam; Tigecycline | 2022 |
Acinetobacter baumannii response to cefiderocol challenge in human urine.
Topics: Acinetobacter baumannii; Albumins; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Humans; Iron; Microbial Sensitivity Tests; Siderophores | 2022 |
Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study.
Topics: Adult; Anti-Bacterial Agents; Botswana; Carbapenems; Cephalosporins; Child; Communicable Disease Control; COVID-19; Delivery of Health Care; Drug Resistance, Microbial; Enterobacteriaceae Infections; Hospitals; Humans | 2022 |
Colonization of White-Tailed Deer (Odocoileus virginianus) from Urban and Suburban Environments with Cephalosporinase- and Carbapenemase-Producing Enterobacterales.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Carbapenems; Cephalosporinase; Cephalosporins; Deer; Drug Resistance, Bacterial; Gammaproteobacteria; Humans; Male; Microbial Sensitivity Tests; Plasmids | 2022 |
Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Female; Gentamicins; Humans; Meningitis; Microbial Sensitivity Tests; Middle Aged | 2022 |
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19).
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cyclooctanes; Enterobacteriaceae; Gram-Negative Bacteria; Hydrazines; Lactams; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Tazobactam | 2022 |
A novel, magnetic bead-based extraction method for the isolation of antimicrobial resistance genes with a case study in river water in Malawi.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Genes, Bacterial; Magnetic Phenomena; Malawi; Rivers; Water | 2022 |
Enterobacterales high-risk clones and plasmids spreading blaESBL/AmpC and blaOXA-48 genes within and between hospitalized dogs and their environment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Dogs; Drug Resistance, Bacterial; Enterobacteriaceae; Phylogeny; Plasmids | 2022 |
Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Asia, Southeastern; Blood Culture; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nebramycin; Pseudomonas aeruginosa; Tobramycin | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
Antibiotypes and high frequency of toxin genes in methicillin-resistant Staphylococcus pseudintermedius from nares of dogs and dog guardians in Nigeria.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Dog Diseases; Dogs; Fluoroquinolones; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nigeria; Staphylococcal Infections; Staphylococcus | 2022 |
Prevalence, etiology and antibiotic resistance patterns of community-acquired urinary tract infections in Dhaka, Bangladesh.
Topics: Adult; Anti-Bacterial Agents; Bangladesh; Carbapenems; Cephalosporins; Coagulase; Community-Acquired Infections; Cross-Sectional Studies; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Female; Fluoroquinolones; Humans; Klebsiella; Macrolides; Male; Penicillins; Prevalence; Urinary Tract Infections | 2022 |
Dynamic antimicrobial resistant patterns of Escherichia coli from healthy poultry and swine over 10 years in Chongming Island, Shanghai.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Penicillins; Polymyxins; Poultry; Sulfonamides; Swine; Tetracyclines | 2022 |
Beta-lactam hypersensitivity diagnosis in ambulatory and hospitalized settings require different approaches.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Hypersensitivity, Immediate; Penicillins; Skin Tests | 2023 |
HEALTHCARE-ASSOCIATED TUBO-OVARIAN INFECTIONS IN UKRAINE: RESULTS OF A MULTICENTER STUDY (2020-2022).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Methicillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ukraine; Vancomycin | 2022 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Phage-Plasmids Spread Antibiotic Resistance Genes through Infection and Lysogenic Conversion.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; DNA Transposable Elements; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Plasmids; Plastics | 2022 |
Resistance Pattern in Mostly Gram-negative Bacteria Causing Urinary Tract Infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections | 2023 |
Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Data Mining; Molecular Docking Simulation; Monobactams; Penicillins; Tazobactam | 2022 |
Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Retrospective Studies; Salvage Therapy | 2023 |
Activity of newest generation β-lactam/β-lactamase inhibitor combination therapies against multidrug resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Monobactams; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Chloramphenicol; Colistin; Drug Resistance, Multiple; Enrofloxacin; Flavobacteriaceae Infections; Nalidixic Acid; Ornithobacterium; Oxacillin; Poultry Diseases; Tetracyclines; Turkeys; Tylosin | 2022 |
Prevalence of Efflux Pump and Porin-Related Antimicrobial Resistance in Clinical
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefepime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Iraq; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Prevalence | 2022 |
Escherichia coli resistance patterns, empiric and targeted antibiotic prescriptions in children: a single center experience.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Infant; Microbial Sensitivity Tests; Prescriptions; Retrospective Studies | 2022 |
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Role of β-lactamase inhibitors on cefiderocol activity against carbapenem-resistant Acinetobacter species.
Topics: Acinetobacter; Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Microbial Sensitivity Tests | 2023 |
In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Pseudomonas aeruginosa; Saudi Arabia | 2023 |
Detection of carbapenemase- and ESBL-producing Klebsiella pneumoniae from bovine bulk milk and comparison with clinical human isolates in Italy.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cattle; Cephalosporins; Female; Fluoroquinolones; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Milk | 2023 |
Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Fluoroquinolones; High-Throughput Nucleotide Sequencing; Humans; Penicillins; Reproducibility of Results | 2023 |
Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Hospitals; Humans; Incidence; Intensive Care Units; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Retrospective Studies | 2022 |
Invasive fungal infection is associated with antibiotic exposure in preterm infants: a multi-centre prospective case-control study.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cephalosporins; Humans; Infant; Infant, Newborn; Infant, Premature; Invasive Fungal Infections; Retrospective Studies | 2023 |
Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests; Monobactams | 2023 |
Evaluation of in-vitro susceptibility of ß-lactam-resistant Gram-negative bacilli to ceftazidime-avibactam and ceftolozane-tazobactam from clinical samples of a general hospital in southern Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Hospitals, General; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tazobactam | 2023 |
Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Liver Diseases; Molecular Epidemiology; Multilocus Sequence Typing; Risk Factors | 2023 |
Clinical and bacteriological profile of culture-negative and culture-proven neonatal sepsis in Palembang, Indonesia.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Indonesia; Infant, Newborn; Neonatal Sepsis; Sepsis | 2022 |
Identification of a novel carbapenem-hydrolysing class D β-lactamase RAD-1 in Riemerella anatipestifer.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Escherichia coli; Kinetics; Monobactams; Penicillins | 2023 |
Satisfactory In Vitro Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Pseudomonas aeruginosa; Tazobactam | 2023 |
Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cattle; Cephalosporins; Chickens; Drug Resistance, Bacterial; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Swine | 2023 |
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2023 |
Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Salvage Therapy | 2023 |
Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Microbial Sensitivity Tests; Plasmids | 2023 |
Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefiderocol; Cephalosporins; Enterobacter cloacae; Microbial Sensitivity Tests; Siderophores | 2023 |
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Doripenem; Humans; Imipenem; Leadership; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
Susceptibility of ceftolozane/tazobactam against multidrug-resistant and carbapenem-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2023 |
Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Ertapenem; Escherichia coli; Humans; Propensity Score; Prospective Studies; Shock, Septic | 2023 |
Risk factors for colonization with multidrug-resistant Gram-negative bacteria and
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Long-Term Care; Prevalence; Risk Factors | 2023 |
Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Microbial; Hospitals; Humans; Kenya; Monobactams; Risk Factors | 2023 |
High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Chile; COVID-19; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Risk Factors | 2023 |
Prevalence of Colonization With Antibiotic-Resistant Organisms in Hospitalized and Community Individuals in Bangladesh, a Phenotypic Analysis: Findings From the Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Topics: Adult; Anti-Bacterial Agents; Bangladesh; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Microbial; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Prevalence; Staphylococcal Infections | 2023 |
Human serum albumin-induced modification of Ton-B-dependent receptor expression in cefiderocol-exposed carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests | 2023 |
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
Topics: Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies | 2023 |
Convergent
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefiderocol; Cephalosporins; Disease Outbreaks; Klebsiella pneumoniae; Multilocus Sequence Typing | 2023 |
Antibiotic point prevalence survey and antimicrobial resistance in hospitalized patients across Peruvian reference hospitals.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Microbial Sensitivity Tests; Peru; Prevalence | 2023 |